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Abstract   
Maintaining cognitive ability in the elderly is a global priority. In this regard, 
Computerised cognitive training (CCT) is among the few effective interventions but 
several gaps in the evidence base limit clinical implementation. Specifically, we do 
not understand which specific cognitive skills can be effectively targeted, which 
design features moderate efficacy, or the nature of the underlying neuroplastic 
mechanisms. To address this problem, three inter-related studies were conducted.  
Chapter 2 is the first systematic review to utilise meta-analysis and meta-regression 
techniques to evaluate randomised controlled trials (RCTs) of tightly-defined CCT in 
healthy elderly. Three hundred forty-four effect sizes were generated from 37 RCTs, 
encompassing a total of 4,310 participants. Overall, CCT was effective on memory, 
working memory, processing speed, attention, language and visuospatial skills, but 
not on executive function. Type of training program, mode of delivery, session length 
and training frequency were found to moderate CCT efficacy.  
These design features were implemented in the Timecourse Trial (Chapter 3), a 
randomized, double-blind, active controlled longitudinal RCT of CCT in 80 healthy 
elderly. Significant effects were found on global cognition, memory and processing 
speed, as well as distinct dose-response curves across domains. These domain-
specific gains also followed different decay curves after training cessation, yet 
positive residual effects were still noted at 12 months follow-up.  
Gains in global cognition were next (Chapter 4) revealed to be related to discrete 
functional and structural brain changes using multimodal MRI on a subsample from 
the Timecourse Trial. Modification of resting-state functional connectivity was found 
to predict subsequent cognitive gains, gains that were also correlated to structural 
cortical plasticity.  
Overall, these results suggest that CCT is an effective intervention for supporting 
cognition in the elderly. The field may do well to now focus on improving standards, 
large-scale trials and a further understanding of biological mechanisms. !  
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Chapter 1: Introduction   
But, it is said, memory dwindles. No doubt, unless you keep it in practice, or if you 
happen to be somewhat dull by nature.  
Marcus Tullius Cicero, 44 BCE 
 
Human ageing has been traditionally associated with an inevitable course of cognitive 
decline, but it is now clear that regeneration and experience-dependent plasticity is 
possible in the ageing brain when appropriate interventions are applied1. With 
advanced age the brain is at greater risk of a range of degenerative processes that can 
result in cognitive impairment and dementia, a severe and terminal loss of cognition 
and independence2. At a global scale, declining fertility rates and enhanced longevity 
have brought about pervasive, enduring, and largely irreversible changes to the age-
structure of national populations3. These sociodemographic transformations underpin 
a growing recognition that age-related cognitive decline is one of the key challenges 
of the century4.  
Whilst the neurobiological mechanisms of age-related cognitive decline and dementia 
are not fully understood2, it is clear that individual exposure and experience across the 
lifespan are instrumental in defining age-related cognitive morbidity5,6. Indeed, a 
growing body of epidemiological studies show a clear link between several lifestyle 
factors and dementia risk, suggesting that some lifestyle modifications may be 
protective against cognitive decline7. However, the overall evidence base for primary 
dementia prevention of interventional lifestyle modifications is currently limited8.    
This chapter will therefore introduce the potential role of computer-assisted 
cognitive training (CCT) as a means to improve cognition and reduce the risk of 
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cognitive decline in healthy ageing. It begins with a brief overview of healthy ageing, 
mild cognitive impairment (MCI) and dementia, three key stages in the cognitive 
spectrum of late life. It then discusses dementia prevention strategies, with a focus on 
the relationship between cognitive activity and dementia risk. Finally, it provides a 
general introduction to CCT, its development and the current state of the literature on 
CCT in older adults.  
1.1 Ageing, Cognition and Age-related Cognitive Decline  
The proportion of people around the world over 65 years of age has grown from 8% 
in 1950 to 11% today but is expected to double by mid-century3. The growth curve is 
expected to decelerate in the second half of the century, reaching about one-third of 
global population in 21009. The one-third mark is expected to occur before 2050 in 
several regions, including Europe, Japan and Oceania, where current fertility and 
mortality rates have already caused significant demographic changes9. Approximately 
3.2 million Australians are aged over 65 (14% of total population), and the age 
brackets 65-74 and >85 are the fastest growing segments in Australia10. China may 
face even greater demographic challenges, as growth in the >65 age bracket is 
coinciding with significant shrinkage in the working-age population11. The clear link 
between advanced age and morbidity implies that the challenges on the healthcare 
system are, immediate, acute and escalating5.     
Increasing longevity is not only a global challenge but also an opportunity for testing 
the impact of cognition-enhancing interventions to prevent or delay age-related 
cognitive decline (ARCD). As evidence of cohort effects in physical and cognitive 
morbidity accumulate5,12,13, and the interest in delaying retirement age and 
redistributing work across the age brackets is growing14,15, there is increased 
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likelihood that cognition-enhancing interventions could produce substantial societal 
impact.  
1.1.1 Normal Cognitive Ageing 
Whilst prescriptive definitions of ‘normal’ or ‘healthy’ cognitive ageing remain 
elusive, most older adults are psychometrically within the normal range of the 
cognitive ageing continuum depicted in Figure 1.116,17. Here, the general premise of 
normal ageing is an absence of a diagnosed cognitive impairment18, i.e., exclusion of 
performance on one or more neuropsychological tests below the 10th percentile. As 
almost all older adults tend to show some degree of deterioration in cognitive 
performance compared to younger adults2,19, it follows that so-called normal cognitive 
ageing allows for a degree of cognitive decline up to a normative level defined by 
respective age-, sex- and education-matched data18. Cognitive performance below 
one-to-two standard deviations (SD) of the norm generally marks the difference 
between normal cognitive ageing and mild cognitive impairment (MCI) (further 
defined below) 20. 
While convenient for both clinical and research purposes, the premise of normal 
ageing raises several important issues. First, it implies acceptance of ARCD as a 
natural part of ageing. In an ageing world, tacit acceptance of this notion and failure 
to take measures to combat this phenomena may turn out to be extremely expensive15. 
This is mainly due to the growing importance of older adults in the labour market, 
while jobs are becoming more cognitively demanding in today’s knowledge 
economy14,21. Hence, initiatives that effectively maintain and enhance cognitive 
performance in late life would not only decrease dependency ratios, but are arguably a 
prerequisite for economic stability.   
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Figure 1.1: The spectrum of cognitive impairment 
Source: reproduced from Bullock22  
Second, normal ageing encompasses an extremely heterogeneous set of cognitive 
profiles (phenotypes) and trajectories23 that often overlap with those of MCI24. Apart 
from neurodegenerative pathology, cognitive deficiencies may arise for several 
reasons including, among others, depression7, low midlife premorbid intelligence18, 
sensory impairment25, sleep disturbance26, cerebrovascular disease27, and 
cardiovascular disease and other physical comorbidities18. Thus, individual risk 
factors and domain-specific impairments, even when still at a preclinical stage, should 
be addressed in order to prevent subsequent decline.  
Finally, up to 30% of older adults with normal cognitive performance may have 
clinically silent Alzheimer’s disease (AD) pathology such as amyloid-β plaques, 
which may or may not develop into clinical dementia in later life28,29. Therefore, 
psychometrically normal cognition at a singe timepoint does not rule out the need for 
periodical evaluation, as every additional year of life increases the risk of dementia. In 
this way, the entire normal ageing population can be considered at general risk for 
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dementia, risk that might be mitigated or exacerbated by the presence of absence 
other risk factors.  For these reasons, there is a strong case for cognitive interventions 
in the ‘normal’ cognitively ageing population for the purpose of primary prevention 
of cognitive decline and dementia.  
1.1.2 Mild Cognitive Impairment 
MCI involves cognitive decline greater than expected for an individual’s age and 
education level but that does not interfere notably with activities of daily life, and is a 
frequent precursor of overt dementia30. The prevalence rate of MCI is estimated at 10-
20% of the elderly (>65) population31, but prevalence and incidence figures vary 
significantly, mostly due competing operational definitions and incorrect 
diagnoses32,33. Pusswald et al24, for example, compared two methods for MCI 
diagnosis in a cohort of memory clinic outpatients. In their study, 84.3% of the cohort 
was diagnosed as MCI using one method, but prevalence in the same cohort using a 
different method was less then half (39.5%).    
MCI is a broad term for a range of cognitive deficits, and several definitions have 
been proposed to differentiate it from normal ageing and to improve its diagnostic and 
prognostic value. The most notable differentiation is between amnestic and 
nonamnestic MCI (aMCI and naMCI, respectively) as well as single- and 
multidomain MCI 31. The difference between aMCI and naMCI is the presence of 
memory impairments, and multidomain MCI denotes that more than one domain (in 
addition to memory in aMCI) is impaired. The neuropsychological differentiation can 
be further categorised by the probable aetiology of the impairment, including, among 
others, AD, vascular dementia (VaD), frontotemporal dementia (FTD), psychiatric 
6   
disorders and medical conditions such as metabolic deficiencies and head trauma, or a 
combination of several sources34 (see Figure 1.2).   
 
In a recent position statement, Albert et al20 set out four diagnostic characteristics for 
MCI: concern regarding change in the patient’s cognition, impairment (>1 standard 
deviation from the matched age and education norm) in one or more cognitive 
domains, preservation of independence in functional abilities, and no dementia, albeit 
with evidence of cognitive deterioration. The statement recommends incorporating 
AD biomarkers in the diagnostic process to assess whether the observed MCI 
symptoms are likely to be early signs of AD, as MCI patients, particularly aMCI, are 
about 10 times more likely to develop dementia than those with normal cognition at 
the same age strata and thus may benefit from secondary prevention 
interventions31,33,35. Conversely, most MCI will remain stable or revert to normal 
cognition31,32, and since the benefits of pharmacological interventions in MCI are 
limited35, the clinical logic of pharmacological interventions to prevent conversion 
from MCI to dementia is unclear.  
MCI represent some degree of deviation from normal cognition and is an important 
dementia risk factor31,33, but is it a diagnostic entity in its own right or simply 
Once the physician hasmade the
delineation of the clinical subtype of
MCI, the next step involves the de-
terminati n of the proposed etiol-
ogy of the syndrome as outlined in
Figure 2. This approach is similar
to that used in delineation of most
neurological diagnoses, including
dementia. If by history, examina-
ti n, and laboratory testing, e con-
cludes that the amnestic subtype is
likely caused by a neurodegenera-
tive process, then the probable out-
come will be AD, as has been sup-
ported by progression tomore severe
stages of dementia and by neuro-
pathological findings.18,19 The in-
sidious onset of symptoms that typi-
fies AD suggests that virtually all
affected individuals will experi-
ence MCI as the earliest clinical ex-
pression of the underlying AD pro-
cess. Therefore, if a physician were
interested in designing a random-
iz d clinical trial for AD, the appro-
priate clinical subtype of MCI, am-
nesticMCI, could be combinedwith
the suspected degenerative etiol-
ogy and inclusion and exclusion cri-
teria for the trial could be designed
appropriately. This basic approach
has been successful in characteriz-
ing a uniform group of individuals
to participate in randomized clini-
cal trials for MCI, using drugs that
are purported to have a mechanism
relevant to the underlyingADpatho-
logic features.
It is likely that the lack of con-
sideration of the etiology of the clini-
cal subtypes of MCI has led to s me
of the variability in the literature.
Epidemiology studies characterize
MCI subtypes cl nically and evalu-
ate the subjects longitudinally. How-
ever, as Figure 2 demonstrates, some
etiologies of amnestic MCI (eg, ma-
jor depression) would be expected
to improve. Therefore, the general
statem t that MCI is “unstab e” is
inappropriate since it implies a prob-
lem with the construct of MCI. On
the contrary, some types of MCI of
certain etiologies should improve.
However, if one were to restrict the
d scussion to the amnestic subtype
of presumed degenerative etiology,
then the predictive value of the con-
struct as pr dromal AD is borne out.
It is only when the subtypes of MCI
are discussed broadly without ref-
er nce t the tiology that the con-
fusion arises. The appreciationof this
interpretation of the literature re-
flects increasing sophistication of the
construct over the years.
IMPLEMENTATION
OF CRITERIA
Some variability is introduced by the
manner inwhich the criteria forMCI
are used. Recently, the construct of
cognitive domains has been intro-
duced to subclassify the various
types of MCI. Inherent in this no-
tion is the definition of a domain and
the instruments used tomeasure that
domain.While there is some agree-
ment on which domains are rel-
evant, there is no onsensus. How-
ever, this is not different from the
application of the criteria for the di-
agnos s of dementia or AD.20 These
definitions also require impair-
ment of memory and other cogni-
tive domains (eg, a tention, lan-
guage, visuospatial skills), as well as
a functional impairment. There-
fore, the challenge is s mil r; the
physicianmust determinewhat con-
stitutes a given cognitive domain,
such as memory, and use ppropri-
ate instruments for measuring that
domain. There are no specific rec-
ommendations in the criteria for de-
mentia or AD with respect to what
constitutes specific domains or how
he physician shouldmeasure them.
In addition to the definition of a
domain, the physician must decide
how to assess the d mains. Does the
physician use 1, 2, or more mea-
sures ofmemory, for example, to de-
termine if memory is impaired?
Clearly themoremeasures the phy-
sician uses, the more reliable the
measurements will be. Some of the
variability seen in the epidemio-
logic studies concerning MCI may
relate to the tendency to use a single
measure to assess a domain such as
memory. If that domain forms the
cornerstone for the definition ofMCI
and the subjectswithMCI as a group
are shown to be unstable over time,
then the conclusion may be drawn
that the construct of MCI is not re-
liable when, in reality, it may be the
psychometric measure “instabil-
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Figure 1. Flowchart for diagnosis of mild cognitive impairment (MCI) subtypes.
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Figure 1.2: MCI types and aetiology  
a) diagnostic flowchart for aMCI/naMCI; b) 
possible MCI aetiologies.  
Source: Adapted from Petersen & Morris34 
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unnecessary labelling of the effect of age on cognition36? Differential diagnosis 
between MCI, normal cognition and dementia is imprecise20,34, and prognosis is hard 
to predict. Rather than being described as a medical syndrome requiring specific 
interventions, MCI might be better thought of as a warning sign for possible cognitive 
deterioration and clear reason for frequent evaluation and lifestyle change. That said, 
it is clear that the field in general is gravitating towards the (still controversial) 
medicalization of MCI-like syndromes, as evident by the inclusion of Mild 
Neurocognitive Disorder in DSM-V37. 
1.1.3  Dementia 
Dementia is an umbrella term that refers to various cognitive, functional and 
behavioural syndromes related to neurodegeneration33. The 10th revision of the 
International Statistical Classification of Diseases (ICD-10) defines dementia as 
disturbance in higher cortical functions, which are accompanied with deterioration in 
emotional control, social behaviour, or motivation, but without loss of 
consciousness38. The 5th edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-V) replaces dementia with the term Major Neurocognitive Disorder 
to emphasise the existence of such deficits beyond the realm of ageing as in the case 
of Human immunodeficiency virus (HIV) and brain injury.37 For the sake of 
consistency, this thesis will use the term dementia despite the changes in 
nomenclature.  
The diagnostic core of dementia is clinical and symptomatic rather than 
pathological39. A recent position statement40 defines five criteria of symptoms 
required to diagnose dementia: interference with everyday functioning; decline from 
earlier level of functioning; exclusion of delirium or major psychiatric disorder; 
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evidence of impairment from both subjective (informant interview) and objective 
(neuropsychological or ‘bedside’ mental status testing) sources; and impairment in 
two or more of the following domains: memory, reasoning, visuospatial abilities, 
language functions and behaviour.  
Popular cut-off points for operationalising cognitive criteria include the Alzheimer's 
Disease Assessment Scale-Cognitive subscale (ADAS-Cog) score ≥ 1841, a 
neuropsychological test that covers multiple cognitive domains often used in clinical 
trials, or the Mini-mental State Examination42 <23, a brief screening instrument of 
global cognition. The severity of the impairment and its effect on global functioning 
can be assessed using Clinical Dementia Rating (CDR) scale between 1-343 (see also 
Figure 1.1).  
The most common single aetiology of dementia is AD (accounts to 60-80% of 
incidence), followed by cerebrovascular disease, dementia with Lewy bodies, FTD, 
late-stage Parkinson’s disease, mixed dementia, Creutzfeldt-Jakob disease, and 
normal pressure hydrocephalus (for characterisation of the various types see e.g., 
Thies et al33). Importantly, population-based neuropathology studies suggest that 
multiple pathology is in fact more common than any single pathology, with AD and 
cerebrovascular disease being the most common combination44. 
Since dementia mainly occurs in late life, global population ageing is associated with 
a sharp rise of prevalence. A recent systematic review estimated the global prevalence 
of dementia at 35.6 million people in 2010, and expected that continuation of the 
status quo would see this number doubles by 203045. However, recent evidence of 
positive cohort effects in dementia incidence in four Western countries12,13,46,47, 
possibly induced by improvements in health and education in these countries, may 
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suggest that incidence may decelerate in some parts of the developed world. 
However, 58% of all people with dementia live in low- or middle-income countries, 
many of them are lagging behind the Western nations in dementia-relevant aspects of 
public health and education, and the proportion of dementia cases in these countries is 
expected to rise in accordance with increased lifespan to 63% in 2030 and 70%4,45 of 
global prevalence in 2050 (see Figure 1.3A). The global cost of dementia was 
estimated at US$604 billion in 2010, about 1% of the world GDP48, and is expected to 
increase faster than prevalence due to rising costs of patient care49. Therefore, the 
world’s weakest economies are taking most of the burden of the disease, leading to 
profound economic and humanitarian pressures. As current pharmacological 
interventions for dementia provide merely short-term symptomatic relief in a subset 
of patients50, preventative strategies that focus on key risk factors are extremely 
compelling areas for global action4.  
 
Figure 1.3: Dementia prevalence (A) and costs per patient (B) in high low-to middle-income 
countries 
Source: Wortmann51  
1.2 Preventing Dementia   
Given that AD is the most common cause of dementia and that most cases occur after 
65 years33,45, this review focuses on preventing AD dementia in the elderly 
population. Furthermore, the main focus here is on modifiable risk factors that can be 
potentially addressed with interventions, with an emphasis on cognitive inactivity as a To e hance global public policy on dementia, ADI has 
released reports on the global prevalence of dementia 
(World Alzheimer Report 2009), the economic cost of 
dementia (World Alzheimer Report 2010) and the bene-
fi ts of early diagnosis and intervention (World Alzheimer 
Report 2011). ADI worked with the World Health 
Organization on the report Dementia: A Public Health 
Priority that was launched in Geneva in April 2012 [3] . 
Th is report confi rms previous data and provides an 
overview for all aspects of the disease. Th e report 
recommends that every country should develop a 
national Alzheimer and dementia plan, and gives a 
framework for action. Th is framework includes the 
following stages [5].
Th e framework initially involves advocacy and 
awareness raising. Advocacy targets governments at all 
levels to encourage policies that will improve dementia 
care and services. Awareness raising focuses on the 
general public, as well as families and healthcare profes-
sionals, to improve their understanding of dementia and 
to change attitudes and practices.
Developing and implementing dementia policies and 
plans should be carried out across governmental depart-
ments on all medical, social, legal and economic aspects 
of the disease. Plans should be put together and imple-
men ted in collaboration with academia, nongovern men-
tal organisations, professional organisations and govern-
mental departments and agencies.
Th e third stage of the framework concerns health and 
social system strengthening. It is essential that health and 
social systems are equipped to provide the range of care 
and services that people with dementia and family 
caregivers need. Th is includes capacity-building and edu-
ca tion among healthcare professionals and invest ments 
in health information systems.
Finally, research and evaluation should complete the 
framework. Each country should develop a research 
agenda, and there is need for international collaboration 
and public/private partnerships to make progress in basic 
science and fi nding new and more eﬀ ective treatments. 
Th e agenda will be multidisciplinary. Countries also need 
to monitor the course of the dementia epidemic for 
changes in prevalence and incidence that might indicate 
success or failure of measures.
ADI wants to work with its member organisations and 
other international nongovernmental organisations to 
make this framework happen.
A number of countries now have Alzheimer or 
dementia plans – for instance, Australia, South Korea, 
France, the UK, Norway and Denmark. Th e USA is 
working on a plan and has published a draft. Th ere are 
also policy initiatives in Mexico and India. Th ese plans 
are promising and other countries can learn from the 
fi rst experiences. From the data, it is clear that we have 
no time to lose!
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leading modifiable risk factor7. However, given that different types of dementia have 
overlapping risk factors (e.g., cardiovascular disease) and that some interventions may 
be used for both prevention and moderation of AD, the discussion on cognitive 
interventions in the second half of this section may also be relevant to other aspects of 
the dementia epidemic.  
1.2.1 The Rationale Behind Prevention  
Dementia is associated with three types of costs whose composition vary between 
different economies (see Figure 1.3)48,51. Direct medical expenditure (i.e., spending 
within the health care sector) accounts for about 15% of the total global expenditure 
on dementia and is the least common expenditure, although dementia contributes to 
some extent hospitalisation due to other causes52. Direct expenditure on social care 
(institutionalisation) accounts for about a third of total global costs, but vary between 
45% of the cost of care in high-income countries to about 13% in low- to middle-
income countries. Finally, the cost of informal care (i.e., indirect costs incurred by 
caring for people with dementia at home or in the community) accounts for 40% in 
high-income countries and may reach 65% of the economic burden of the disease in 
lower-middle income countries. These costs may be an underestimation, as the costs 
may cover multiple parameters, from loss of income to mental health morbidity on 
behalf of carers.  
While much can be made to improve the quality and efficiency of dementia care and 
medical treatments, there is little argument that reduction of dementia prevalence is a 
key element in reducing the burden of dementia. The progressive nature of the disease 
and its late age of onset allow for four types of prevention strategies along the 
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dementia continuum (Figure 1.1): primary prevention, secondary prevention, tertiary 
prevention and delayed onset.  
Primary prevention aims to reduce the incidence of conversion from normal cognitive 
function to clinical cognitive impairments (i.e., MCI and dementia)53. Secondary 
prevention targets populations with MCI with or without biomarker evidence of AD 
pathology in order to prevent further deterioration towards dementia8. Tertiary 
prevention aims to prevent progression in severity of diagnosed dementia, or reduce 
the degree of functional impairment50,53. Finally, delay onset strategies aim to 
compress the duration of the disease, i.e., to reduce the time between diagnosis and 
death. Since delayed onset strategies aim to extend the age of diagnosis, they could be 
thought of as a form of primary prevention.   
Several theoretical models have suggested that effective interventions can serve 
multiple prevention strategies, i.e., delay both onset and progression, bringing about a 
significant long-term reduction in prevalence54,55. For example, a recent Australian 
model55 associated every year of delayed onset by an intervention introduced in 2020 
with a 7% reduction in prevalence three decades later. The net effect of such 
interventions on future prevalence depend on a number of factors, including the 
period of delayed onset and/or progression, the year in which the intervention will be 
introduced, types of dementia likely to be affected, the timeframe of the model and 
epidemiological predictions in the relevant geographical region54,55.  
An alternative approach models the effectiveness of specific preventative 
interventions according to the relative weight of the risk factors reduced by each 
intervention7. Importantly, all of these models rely on assumptions about age-linked 
increases in prevalence and incidence, which, as mentioned previously, are coming 
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under increasing scrutiny given evidence for protective cohort effects12,13,46,47. 
Clearly, further epidemiological research is required to test the predictive accuracy of 
these models. 
1.2.2 Preventing Dementia by Targeting Risk Factors  
Whilst the theoretical benefit of preventative intervention is clear, establishing 
empirical evidence has proven exceptionally challenging. Several factors may be 
responsible, including the heterogeneity of dementia pathogenesis and failure to 
intervene well ahead of the development of AD pathology8,17. More importantly, since 
incident dementia event rates are low (e.g., 1,8% [95% CI 0.9–3.6] in the age bracket 
65-6913), previous prevention trials have been underpowered, poorly targeted, or both.  
In contrast to the absence of such empirical data, a rapidly growing body of 
epidemiological studies have identified a range of factors that increase the risk of 
ageing-related cognitive decline, MCI and conversion to dementia, that may therefore 
serve as a basis for developing preventative interventions56.  
Two leading risk factors are unmodifiable. First and foremost is increasing age; the 
incidence of dementia doubles every 5.9 years of age, from 3.1 per 1000 person years 
in the age bracket 60-64 to 175 at those aged over 954. The second is hereditary, 
which includes a combination of some genetic variants such as the ε4 form of 
apolipoprotein E (APOE) gene, other genes that increase dementia-related morbidity 
(e.g., cardiovascular disease) and early life environmental risk factors33. The 
hereditary nature of mid- and late-life intelligence17 may play an additional role, as 
intelligence level is assumed to be inversely related to dementia risk7.      
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Conversely, several cardiovascular risk factors have been strongly associated with 
dementia incidence and seem to be more malleable. These mainly include midlife 
hypertension, obesity, high cholesterol and diabetes mellitus, as well as high-
cholesterol diet, smoking and physical inactivity7,33,57. Several interventions inspired 
from cardiovascular disease prevention trials have been found to be beneficial to 
maintain cognitive function in the aged. For example, antihypertensive 
pharmacotherapy in the SYST-EUR Trial (first line calcium channel antagonists) is 
the only intervention found to reduce dementia incidence in a multicentre randomised 
controlled trial (RCT)44, however this has yet to be fully replicated44. Cognitive 
benefits (albeit without evidence of dementia incidence reduction) have also been 
found in several trials involving smoking cessation58 and aerobic exercise59. However, 
with the sole exception of SYST-EUR, the association between cardioprotective 
lifestyle factors (including diet and exercise) and reduced dementia risk are restricted 
to epidemiological studies and are yet to be translated into effective dementia 
prevention interventions 16,60. 
1.2.3 Mental Activity, Cognitive Lifestyle and Dementia Risk  
Epidemiological studies repeatedly link a low level of educational attainment with an 
increased probability of dementia incidence7,49,57,61,62, and some studies have further 
found greater education level associated with compression of cognitive morbidity, 
possibly due to delayed onset63 and shortened lifespan following diagnosis63,64. 
Reduced incidence was also associated with a history of engagement in other 
mentally challenging activities such as occupational complexity65, cognitively-loaded 
leisure activities62 and social engagement66. Engagement in an active cognitive 
lifestyle may stimulate several neurobiological effects, including reduction in cerebral 
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microvascular disease, increased neuronal density and cortical thickness in the 
prefrontal cortex67, as well as increased grey matter volume and lower rate of 
hippocampal atrophy in late life68. While the mechanistic underpinnings of these 
effects remain unclear, several theoretical explanations have been suggested.     
First, there are likely causal relationships between early-life intelligence, educational 
attainment and occupational complexity15,17,19, which tend to increase income, 
engagement in mentally challenging leisure activities and tendency towards healthier 
behaviour69. Similarly, cognitive abilities predict job performance, coping with 
challenges and thus income15,70, which, in turn, is associated with decreased dementia 
risk49,71 (see Figure 1.4). However, some research suggests that different forms of 
cognitive lifestyle may have distinct effects. For example, dose-dependent and 
education-independent effects of cognitive activity in late life have been found on the 
onset of memory decline72, as well as domain-specific effects of particular cognitive 
activities73, which together suggest that activities may differ in the scope and scale of 
their long term benefits to cognitive function.  
Second, complex mental activities across the lifespan (but also premorbid 
intelligence) are often associated with the concept of reserve, which aims to explain 
“differences between individuals in susceptibility to age-related brain changes and 
pathology”74(Stern, p. 1006). Very briefly, one form of the reserve theory proposes 
that the effect of any neural injury (e.g., AD pathology) on brain and cognitive 
function is moderated by some premorbid neurophysiological or cognitive capacities 
(brain and cognitive reserve, respectively). As a result, individuals with higher reserve 
will require more pathology to induce loss of function compared to individuals with 
lower reserve, thereby delaying the onset of clinical symptoms and increasing the rate 
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of decline once the latter has started75. Furthermore, cognitive reserve underpins 
individual differences in strategy and brain function during task performance, which 
can compensate for pathology and cognitive decline and protect everyday functions75. 
Cognitive reserve has been associated with higher IQ, education, occupational 
attainment, some leisure activities and social engagement in both epidemiological61 
and imaging studies75. The clearest evidence for a compensatory effect of education 
on dementia is provided by the ECLIPSE multicentre neuropathology collaboration76, 
which found that dementia risk for a given level of AD pathology was independently 
mediated by education level. 
 
Figure 1.4: Probability of dementia by household income 
Source: based on data from Hurd et al49. Error bars represent 95% CI    
 
The current definitions of cognitive lifestyle are too broad to provide clear causal 
links between specific lifestyle modifications and positive cognitive results. More 
specific evidence, particularly in regard to the type, intensity and implementation of 
effective cognitive activities is needed to facilitate clinical translation. Nevertheless, 
interventions that can effectively increase educational attainment and other forms of 
cognitive stimulation earlier in life may affect cognitive morbidity, especially in the 
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developing world77. In parallel, there is a pressing need to develop specific and 
effective forms of cognitive enhancement for populations at risk for dementia. This 
thesis explores the CCT as a possible strategy to meet this challenge.     
 
1.3 CCT in Older Adults: A Primer 
The first evidence of cognitive training (CT) go back to Greek poet Simonides of 
Ceos, who introduced mnemonic strategy training in the 5th century BCE “as a 
technique by which the orator could improve his memory, which would enable him to 
deliver long speeches from memory with unfailing accuracy78” (p. 2). Simonides’ ars 
memorativa (“method of places and images") was practiced in rhetoric and monastic 
contexts through the Middle Ages, along with training aids such as Ramon Lull’s 
combinatory wheels, which helped practitioners to remember Christian concepts 
through the use of enumeration and grouping. From the late Renaissance onwards, 
memory training was conceived as a systematic method involving repeated practice 
on structured tasks, and as an aid for scholastic thinking and logic (rather than merely 
memorising) as part of the emergence of the scientific method 78,79.  
The basic approach of modern-day CT is founded on early trials of cognition-focused 
psychotherapy in patients with psychiatric illness, brain injuries and other cognitive 
disorders during the 1960s80,81. The notion that the malleability of cognitive 
performance extends to non-clinical populations became evidently clear in the 1970s, 
and training programs aimed at improving cognitive performance in the elderly were 
introduced immediately thereafter82-84.  
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Several CT methods have been proposed to target cognition in older adults, based 
mostly on domain-specific strategy training and multi-modal approaches, which 
combine strategy training in several neuropsychological domains accompanied with 
general cognitive stimulation programs (for an overview of the evolution of these 
interventions, see a review by Lustig et al85). Recent years have seen a surge of 
interest in interventions that involve extended practice on cognitive processes86-88, 
including computer-based exercises, which were introduced in the early 1980s and are 
gaining popularity89.   By mid-2013, more than 2,000 peer-reviewed articles have 
been published on the topic (see Chapter 2), and the scientific interest in CT 
applications seems to be growing exponentially (see 1.5).   
 
Figure 1.4: Number of publications per year on CT, 1973-August 2013 
Source: ISI Web of Knowledge (see Chapter 2 for search details) 
 
CT is often framed as a type of cognitive remediation90, defined as “a behavioral 
training based intervention that aims to improve cognitive processes (attention, 
memory, executive function, social cognition or metacognition) with the goal of 
durability and generalization91” (p. 472), along with other cognitive-based 
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interventions such as cognitive stimulation and cognitive rehabilitation (see Figure 
1.6).  
 
Figure 1.5: A typical view of CT in broader context of remediation  
Source: Mowszowski et al90 
 
However, it can be argued that classifying CT in the context of cognitive remediation 
present three problems. First, it incorrectly equates CT with incomparable 
interventions and obscures the specific methods and effects of CT, as evident by 
Cochrane reviews that attempt to synthesise a considerably heterogeneous array of 
non-CT trials (involving e.g., behavioural interventions and general stimulation 
activities) 92,93. Second, defining CT this way may incorrectly narrow down the utility 
of the intervention to clinical populations, whereas training-induced benefits have 
been documented in high-functioning populations as well. Third, CT is not a generic 
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COGNITIVE
REMEDIATION
Intervention strategies to
mediate deterioration in
memory and other cognitive
domains
Cognitive Stimulation
Participation in activities
which generally enhance
cognitive and social
functioning, using non-specific
techniques such as
discussions or reminiscence
Cognitive Training
Provides theoretically driven
strategies and skills and
involves “guided practice” on
various tasks reflecting
specific cognitive functions
Cognitive Rehabilitation
Relies on identifying and
targeting individual areas of
weakness in daily functioning,
and implementing strategies
to improve or compensate for
these difficulties
Strategy-based:
Teaches and facilitates
practice of techniques to
enhance strengths and/or
adapt to weaknesses;
includes both internal and
external strate iesg
Computerized:
Games and exercises
targeting various cognitive
functions; usually individually-
tailored and incorporates
graded difficulty and
independent learning
Internal:
Incorporate mental
techniques to facilitate
cognitive processes – e.g.
“chunking’ pieces of
information to assist
encoding”
External:
Use practical aides to
compensate for weaker
cognitive processes – e.g.
writing information down to
reduce the burden on memory
processes
Figure 1. Cognitive remediation terminology.
Sources: Medalia and Richardson, 2005; Sitzer et al., 2006; Acevedo and Loewenstein, 2007; Belleville, 2008; Clare and Woods, 2008.
Cognitive remediation and cognitive training
Cognitive remediation refers to behavioral interven-
tions aimed at improving cognition in individuals
who have experienced a decline in cognitive
functioning, or enhancing and extending function-
ing in those who are cognitively intact (Medalia
and Richardson, 2005; Acevedo and Loewenstein,
2007). These interventions may be administered in
individual or group formats over several sessions,
and involve a range of activities including general
mental activity, guided practice on cognitively
demanding tasks, strategy use and computerized
exercises. The literature uses many terms to
describe cognitive remediation techniques, such
as cognitive stimulation, cognitive rehabilitation
and cognitive training, all of which differ in
their approach (Belleville, 2008; see Figure 1).
This review focuses on cognitive training (CT),
referring to programs which enhance cognition by
providing theoretically-driven strategies and skills,
usually involving “guided practice” on various
tasks reflecting different cognitive functions. CT
techniques are categorized as compensatory or
restorative (Sitzer et al., 2006). Compensatory
tactics aim to develop new ways of performing
tasks, bypassing deficient cognitive processes and
teaching alternative approaches to achieving goals.
Both internal (e.g. categorizing, visualizing or
paraphrasing information during learning) and
extern l (e.g. using calendars or environmen al
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intervention, but a rather diverse field with distinct methodologies that are 
substantially independent from other forms of cognition-focused psychotherapy. 
1.3.1 Refining the Nature of Cognitive Training  
CT can be defined as repeated practice on one or more tasks with inherent cognitive 
challenge (‘cognitive exercises’), for the purpose of improving performance in 
specific cognitive domains50,94,95. Such improvements are attributed to the process 
overlap between the exercises and the cognitive domains they target, which can be 
measured using cognitive tests and/or functional outcomes (transfer tasks). CT can be 
based on teaching cognitive strategies or on extended practice over hundreds or 
thousands of trials on tasks that are based on the same theoretical grounds as 
cognitive tests86. Measuring the transferability of the latter kind might be challenging, 
as some exercises may closely resemble the transfer tasks (for a comprehensive 
review of transfer of training in older adults, see Zelinski86).  
Each cognitive exercise usually targets one or two specific cognitive domains, but it is 
possible to target the same domain using different exercises. That is, just like the 
pectoralis major muscle can be trained with various resistance exercises (e.g., push 
ups and bench pressing), response inhibition can be trained using diverse stimuli (e.g., 
shapes or letters), delivery methods (e.g., computerised or paper-based), speed, levels 
of stimuli complexity and so on. This does not mean that all response inhibition 
exercises are born equal – there is indeed a good reason to assume that some would be 
more efficient, acceptable or effective than others – but the principle that different 
exercises can target similar cognitive processes still holds, and optimising the content, 
delivery and dose of CT exercises for specific populations is a growing area of 
research96.      
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In contrast to the nature of CT as a means to deliver practice of cognitive processes, 
other forms of cognitive remediation use different intervention techniques, such as 
skill learning, social interactions, engagement in cognitively stimulating activities, 
coping strategies and individually-tailored CT-like programmes50,90,94,97. CT can be 
combined with remediation techniques, physical exercise and/or pharmacological 
interventions, but the CT component of such combined approaches is still distinct 
from the other. Thus, models such as the one depicted in Figure 1.6 are arguably 
incorrect, and better description of the interventions in trials of non-pharmacological 
interventions98 may help the field to better interpret the evidence.  
Moreover, the field lacks coherent terminology to distinguish CT from non-CT 
interventions, as well as one CT approach from another. Terms such as ‘cognitive 
training99’, ‘brain training100’, ‘brain plasticity-based training101’, ‘mental activity102’, 
‘video game training103’, ‘brain exercise104’, ‘cognitive exercise105’, ‘cognitive 
rehabilitation training106’ are just a few examples of terms used to describe multi-
domain CCT programs in publications. Conversely, using the same term to describe 
inherently different CT programs may be just as problematic, as such practices 
establish the idea that all CT programs are identical.   
This is not a semantic issue but rather a fundamental problem in the current literature, 
which slowed down progress95. Sloppy terminology could lead to poorly designed 
trials and unsupported claims, underestimating or overestimating the efficacy of 
CT107. Consequently, systematic reviewers try to pool fundamentally different 
interventions (both CT and non-CT) into the same meta-analysis, inevitably finding 
heterogeneous results that are necessarily biased against an indication of 
efficacy92,93,108. It seems therefore that a more detailed taxonomy of cognition-focused 
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interventions is needed to allow the field to settle questions of efficacy (‘does it 
work?’) and then move onto investigation of what works, how it works and for 
whom109. Arguably, it is the latter which are critical for the translation of decades of 
research into clinical practice.     
Rigorously defined CT does not of course rule out the added value of combinatorial 
multimodal interventions. In fact, results from two recent trials suggest that 
combining CT with methods from cognitive rehabilitation and stimulation techniques 
might be effective in older adults. Cheng et al110 found significant and durable 
improvements in healthy older adults’ global cognition after 24 1-hour group 
sessions, which combined repeated practice with group discussions, psychoeducation 
and homework assignments. Similarly, Buschert et al111 combined group-delivered 
extended CT practice with cognitive stimulation techniques in patients with MCI, and 
have shown not only an improvement in global cognition, but also a delay in 
conversion from MCI to AD compared to a wait-list control group112. Unsurprisingly, 
a meta-analysis of memory training (mnemonics strategies) found group sessions 
significantly more effective than individual strategy training, citing “social 
comparison and a resulting feeling of self-efficacy, reactivation, mutual support and 
reinforcement among the trainees, or enhanced motivation” (p. 250) as key possible 
explanation for the mediating effect113. While the mechanisms underlying the added 
value of such ‘non-specific’ effects to CT efficacy are unclear, there may be a case for 
complementing CT exercises with other forms of stimulation, similar to cognitive 
rehabilitation methods in schizophrenia97.     
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1.3.2 Computer-based CT (CCT) 
The following section aims to lay the technical groundwork for the meta-analysis of 
CCT discussed in Chapter 2 and the RCT described in Chapter 3.  
CCT has several advantages over traditional paper-and-pencil CT, including the 
possibility to create engaging, game-like exercises, accurate and rapid individual 
feedback and adaptivity, low administration costs and the option to combine auditory 
with visual stimuli95,114,115. CCT-based interventions can be distinguished by three 
design features, namely, platform, content and method of delivery. Defining these 
features is important because as discussed earlier inconsistent terminology hampers 
understanding and implementation of research results.       
1.3.3 Technical Platforms  
Most CCT trials to date have used personal computers (PCs), with the CCT software 
installed on the PC hard drive, using mice and keyboards. Other input devices include 
touchscreens, joysticks, and – especially in early trials – button boxes. The advent of 
the internet brought about a surge in online CCT, whereby the user does not posses a 
copy of the CCT program, and the provider has absolute control over the provision, 
content and data generated by the software. This feature allows greater flexibility and 
frequent updates of the software, interfaces with other platforms (e.g., emails and 
social media), creating performance norms, monitoring compliance and data analysis 
for research purpose, especially in regard to training performance116.  
Mobile devices pose an alternative CCT platform, which, for reasons of cost, 
simplicity and portability, could be an important mode of delivery in the near future. 
‘Brain training’ suites for the Nintendo DS handheld gaming device received some 
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empirical support100,117, and numerous applications for mobile phones and tablets are 
now available, albeit trials using these two platforms have yet to be published. Video 
game consoles, particularly the Nintendo Wii, have been studied rigorously in recent 
years as a possible platform to provide mainly physical, balance and fine motor 
training, but results from several studies suggest that Wii-delivered CCT in older 
adults can be rather effective as well85,114,118.         
1.3.4 Training Content  
After more than three decades of CCT research, it would be reasonable for the field to 
have identified what design features maximise transfer and focus on development and 
implementation of the most effective programs. Unfortunately, the field has not. A 
recent review of 39 CCT studies in healthy older adults114, for example, identified 31 
different programs. Although innovation is generally a positive feature, it is unclear 
whether the considerable investments in design and research of new CCT programs 
over the past decade are genuine improvements of the methods, or, to borrow a term 
from pharmaceutical industry, simply geared towards ‘me too’ software. 
Notwithstanding the specific differences from one program to another, the structure of 
CCT programs can be divided into three broad categories.  
Single-domain CCT typically entails a small number of exercises (usually between 
one and five), which aim at one cognitive process or at closely related cognitive skills. 
Some popular examples include working memory training109,119, visual processing 
speed training120,121 and dual task training103. This kind of paradigms appeal to 
researchers because they offer a succinct insight into the malleability of a discrete 
cognitive ability87,122, the neural mechanisms underlying training-induced 
adaptations103,123-125, and the role such changes may have on other aspects of cognitive 
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performance126. Single-domain training does not tend to generalise beyond the trained 
domain85, although some evidence for far transfer (i.e., effects that extend beyond the 
trained domain) does exist86,110.   
Along with single-domain programs88, Video games were investigated for potential 
cognitive benefits in the elderly from the early days of CCT89. Video games are far 
from being a single construct with a clear scientific meaning107, but the term is used 
interchangeably with others in the CCT literature. For the sake of clarity it is proposed 
to define ‘video games’ as interventions that were developed for general 
entertainment purposes (i.e., without a therapeutic intentions) and studied for their 
suitability as CCT. This design feature can arguably set video games apart from all 
other types of CCT, which typically have been designed in light of psychological or 
neuroscientific principles and intended for cognitive enhancement96,114. However, as 
long as the lack of regulatory environment for CCT continues, definitions may vary 
and the general misinterpretation of trial results in the media107 is not likely to change. 
Nevertheless, video game training are often considered as a particular type of CCT, 
and a number of RCTs involving video games are reviewed with some caution in 
Chapter 2.      
Finally, and probably the most prevalent type of CCT, multi-domain programs will 
entail two or more exercises targeting two or more cognitive domains. Multi-domain 
training is not to be confused with multi-modal training, as the latter term is used to 
describe programs that combine CT with other interventions, such as physical 
exercise and/or cognitive stimulation85. Some multi-domain CCT programs adjust 
training content to individual needs (based on individual performance), preferences 
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(based on pretraining questionnaires and/or manual selection) or following a 
prescribed program.         
1.3.5 Delivery Methods 
The third design feature that differentiates CCT programs describes the settings in 
which practice takes place. Traditionally, CCT studies have been conducted in a 
designated facility, usually the experimenter’s laboratory. The experimenter’s role in 
the training might me limited to mere technical facilitation of the program, or 
expended to provide guidance, strategy, metacognitive consideration and debriefing.  
Studies involving self-administered training at-home begun to emerge in the late 
1990s and are gaining increasing interest, in line with the increasing popularity of 
CCT via the internet. Some of the self-administered CCT studies provide initial 
training and follow-up (to provide technical assistance, ensure adherence, etc.101,127), 
whereas others merely provide access to the program and do not contact participants 
during the intervention period, similar to how home-based CCT usually works in the 
real world128. Finally, some programs for home use (such as Cogmed, CogniFit and 
Scientific Brain Training Pro) offer add-on case management systems that allow 
clinician to follow-up on trainees’ progress and, in some cases, plan and modify their 
sessions.  
1.4 Thesis Overview 
Designing interventions that can effectively maintain cognition in the elderly is a 
priority in today’s ageing world. Providing more opportunities for cognitive 
stimulation and improving cardiovascular health across the lifespan may help to 
extend recent reports of protective cohort effects 12,13,46,47. These should be 
26   
complemented by interventions designed specifically for older adults at risk for 
ACRD, MCI and dementia. Numerous pharmacological and non-pharmacological 
interventions have been proposed, but most have failed to show efficacy in primary, 
secondary and tertiary prevention trials129,130.  
CT is not a panacea for cognitive ageing, but has accumulated an extensive body of 
evidence for efficacy on elders’ cognitive performance. In addition, CCT is safe, 
highly prescriptive and inexpensive, which makes it a popular intervention in 
prevention-orientated trials. However, in order to advance the field, there is a need to 
address four critical issues, namely ending the ‘brain training debate’ by establishing 
a definitive answer to CCT efficacy (or lack thereof) of CCT, identifying the 
conditions that may facilitate generalisation and durability of any positive effects, 
measuring the dose-responsiveness of these effects and understanding the 
mechanisms of CCT-induced neuroplasticity109. This thesis aims to shed light on 
these four core issues.  
Because systematic reviews of CCT in older adults tend to mix results from studies of 
very heterogeneous methodologies, a definitive review and meta-analysis of RCTs of 
CCT in healthy older adults has yet to be conducted. Chapter 2 provides that first 
systematic review and meta-analysis of strictly defined RCTs of CCT in healthy older 
adults, quantifying not only the efficacy of CCT but also the moderating impact of the 
design features described in Section 1.3 above.   
Identifying the basic anatomy of efficacious CCT programs means the clinical 
applicability of CCT can be further investigated by finding the dose of training 
required to induce cognitive benefits. Chapter 3 reports results from a randomised, 
active-controlled, longitudinal trial of CCT in healthy older adults (the Timecourse 
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Trial), whose main purpose was to measure the dose-responsiveness of key cognitive 
domains to CCT, as well as the timecourse by which such benefits may wane after 
training cessation.  
Finally, Chapter 4 tries to address the challenging problem of understanding the 
neural underpinnings of CCT efficacy. A subset of subjects from the Timecourse Trial 
underwent multi-modality Magnetic Resonance Imaging (MRI) scans before, during 
and after a course of CCT, and results are compared to the cognitive outcomes 
described in Chapter 3.   
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Chapter 2: Dissecting the Anatomy of Computerised 
Cognitive Training: A Systematic Review and Meta-
Analysis  
2.1 Introduction   
2.1.1 Rationale  
Human adult ageing is associated with a gradual process of age-related cognitive 
decline (ARCD). Further deterioration in cognition can lead to mild cognitive decline 
(MCI) and dementia, whose prevalence in adults over 65 years of age is estimated at 
20% and 15%, respectively1 (see Chapter 1 for a detailed discussion of limitations in 
MCI nosology and epidemiology). Given strong links between engagement in 
cognitively stimulating activities and enhanced late-life cognition and reduced risk of 
MCI and dementia2-4 (see Chapter 1), there has been growing interest in cognition-
focused interventions that may attenuate ARCD and help maintain cognitive 
performance in older adults. Arguably, the most studied intervention is cognitive 
training (CT), which involves structured practice on standardised cognitively 
challenging tasks5. Despite a wealth of studies linking CT to various cognitive 
benefits and neuroplastic changes in older adults6-8, the current evidence base is 
methodologically heterogeneous and results inconsistent5.  
Recent years has seen a sharp increase in the popularity of computer-assisted 
cognitive training (CCT) among researchers and the public alike. CCT has several 
advantages over traditional CT methods, including more visually appealing interfaces, 
efficient and scalable delivery and the ability to constantly adapt training content and 
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difficulty to individual performance8-10. However, as in the case of traditional CT, the 
CCT literature suffers from several limitations, including lack of adequate control 
groups, poor study designs, lack of longitudinal follow-ups, unclear relevance of 
study outcomes to everyday performance and inconsistent methodology (in terms of 
e.g., program design, dose and outcome measures). Together, these issues have made 
a synthetic evaluation of the literature challenging and impeded translation of trial 
results to clinical practice5,7,8,11-14.  
To date the efficacy of CCT on cognitive performance in healthy older adults has yet 
to be comprehensively addressed in a systematic review. Three recent reviews5,13,14 
attempted to pool outcomes from different cognition-based interventions (CT, CCT, 
and non-CT methods such as cognitive stimulation) and, unsurprisingly, reached 
inconclusive results. By contrast, a recent systematic review of CCT in healthy older 
adults8 refrained from a quantitative meta-analysis, citing the degree of 
methodological inconsistencies between studies.  
A balance between pooling inherently different studies into the same analysis5 versus 
excess conservatism8 may therefore be required in order to make new insights about 
the efficacy of CCT. One approach is to take advantage of more recent meta-analytic 
technology that allows flexible testing of not only overall efficacy claims, but also 
identification of moderating efficacy factors15. In the context of meta-analysis, 
moderating factors are design features of the included RCTs that can influence their 
effect size estimate.  
2.1.2 Objectives   
In healthy older adults, we aimed to: 
      41
1) Evaluate the efficacy of RCTs of CCT on different cognitive outcomes; 
2) Test the moderating effects of several key design features; 
3) Assess the nature and quality of RCT evidence; and 
4) Suggest recommendations for future CCT research based on these findings.  
2.2 Methods 
The PRISMA guidelines for design, conduct and reporting of meta-analyses were 
implemented16. 
2.2.1 Eligibility Criteria   
Types of studies: Published, peer-reviewed articles reporting results from randomised 
controlled trials (RCTs) studying the effects of CCT on one or more cognitive 
outcomes in healthy older adults.   
Types of participants: Mean participant age ≥60 years and lack of any major 
cognitive, neurological, psychiatric and/or sensory impairments. Studies with MCI as 
inclusion criterion were excluded as cognitive performance in this population may 
vary substantially and conversion from MCI to dementia during the trial period could 
not be ruled out.     
Types of interventions: Trials comparing the effects of ≥4 hours of extended practice 
on standardised computerised tasks with clear cognitive rationale17,18, or immersive 
technologies or video games, administered on personal computers, mobile devices or 
gaming consoles, versus active or passive control condition. Lab-specific 
interventions that do not involve interaction with a computer (e.g., overhead 
projectors and simulators) were excluded from the review. 
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Types of outcome measures: Performance in one or more cognitive tests that were not 
included in the training program (i.e., untrained), administered both before and after 
training. This review is limited to change in performance from baseline to 
immediately post-training on tests of memory, working memory (WM), processing 
speed, attention, language, visuospatial skills and executive functions. Both primary 
and secondary outcomes were included. Long-term outcomes, subjective measures 
(e.g., questionnaires), non-cognitive (e.g., mood, physical) and activities of daily 
living (ADLs) measurements were excluded from the analysis.   
2.2.2 Information Sources and Search  
Studies were identified by searching on all the databases included in ISI Web of 
Knowledge using the search terms "cognitive training" OR "brain training" OR 
"memory training" OR "attention training" OR "reasoning training" OR “extended 
practice”, and by scanning reference lists of articles and reviews. No limits were 
applied for publication dates and non-English papers were translated. This search was 
conducted on 13 August 2013. One additional study published in September 201319 
and results from the Timecourse Trial (Chapter 3) were included as well. The 
candidate developed and conducted the search.  
2.2.3 Study Selection  
Eligibility assessment was performed in three stages. First, the candidate scanned all 
records and excluded ineligible abstracts based on title, abstract and type of record. 
All records that were not peer-reviewed published articles (particularly conference 
abstracts) were excluded at this point as well. Second, the candidate and an additional 
lab member independently scanned the remaining full-text articles for eligibility, and 
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determined inclusion by means of consensus. Finally, the candidate’s supervisor 
assessed eligibility of selected studies.  
2.2.4 Data Collection and Coding  
Coding of outcomes measures into cognitive domains and data extraction was done 
based on accepted neuropsychological categorisation20 or by consensus between the 
candidate and an additional lab member. Data was entered into Comprehensive Meta 
Analysis (CMA21, Biostat Inc., Englewood, NJ) Version 2.2.064.  
Data from most studies were entered as means and standard deviations (SD) of the 
CCT and control groups at baseline and follow-up.  A conservative pre-post 
correlation of 0.6 was selected and preset for all analyses. When studies presented 
data for both active and passive control groups, only the active control group was 
used as a comparison to CCT. In a few instances, data were entered as post-training 
mean change19,22,23, Hedge’s g with 95% confidence interval (CI)24 or raw mean 
difference with 95% CI25.  CMA allows for each of these different study outcomes to 
be flexibly entered into the model. 
When data could not be extracted from study reports, we contacted the authors 
requesting raw data. We contacted 15 authors, of which 12 provided raw data or 
methodological clarifications, after which four papers were excluded due to 
ineligibility26-29. Of the three papers whose authors did not respond or provided the 
requested data, two were excluded30,31, and one was included after reviewing the 
study protocol in the clinical trials registry23.   
Data from two studies received different treatment. First, Wolinsky et al32 presented 
data from four groups, namely: 1) speed of processing (SOP) training on-site, 2) same 
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intervention with long term booster training, 3) SOP training at-home, and 4) an 
active on-site control group. Since groups 1 and 2 received the same intervention 
between baseline and immediate post-training assessment, data (means and SD) from 
these groups were combined using the formulae suggested by Higgins and Green33 
and compared to group 4. Data from group 3 was omitted from the analysis due to 
lack of a matching at-home control group. Second, Colzato et al34 used the same CCT 
in two groups genotyped for the brain-derived neurotrophic factor (BDNF) Val66Met 
polymorphism, compared to genotype-matched (Val/Val or Met-/ carriers) control 
groups. Data from each pair of groups therefore were treated as different studies.  
2.2.5  Data Items   
Information extracted from each included trial included:  
1. Characteristics of trial participants: age, sex (% males), MMSE score (when 
reported). 
2. Intervention details: type of CCT (multidomain, speed of processing (SOP), 
WM training, video games), delivery (centre- or home-based), total dose (in 
hours), number of sessions, session length (in minutes), session frequency (per 
week).   
3. Control condition: active (control intervention) or passive (wait-list or no-
contact) control. 
4. Outcomes: test, subtest/phase (when applicable), targeted domain, form of 
administration (computerised or paper-based), delayed or immediate recall 
(for memory outcome).  
5. Study design: type of control (active or passive control), blinding (unblinded, 
participant-blinded, assessor-blinded, double-blind). 
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2.2.6 Study Quality of Individual Studies 
The Physiotherapy Evidence Database (PEDro) scale was used to assess study 
quality. PEDro is a 11-item scale designed to assess the methodological quality and 
reporting of RCTs, and is reliable for rating trials of non-pharmacological 
interventions35. It should be noted, however, that since one of the PEDro items is 
‘blinding of therapist who administered the therapy’, is yet to be implemented in any 
RCT of CCT, then the maximum score for studies in this review was 10. Two 
independent assessors performed PEDro assessment for each study, and were 
subsequently reviewed by the candidate.   
2.2.7  Summary Measures and Planned Methods of Analysis 
All analyses were conducted using CMA by computing standardised mean difference 
(SMD) between CCT and control groups on each cognitive outcome measure, based 
on a random-effects model with 95% confidence intervals (CI). SMD was calculated 
as the difference in gain from baseline to immediately post-training assessment 
between the CCT and control group. When studies reported several outcome 
measures from the same cognitive domain, all measures of the same domain were 
automatically combined into one outcome measure, a standard feature of CMA. The 
I2 statistic was used to determine the degree of heterogeneity between studies in a 
particular meta-analysis36. I2 values of 25%, 50% and 75% imply small, medium and 
large heterogeneity, respectively36. Forest plots were used to examine the distribution 
of SMDs and to detect outliers.  
Two types of analyses were planned and conducted:   
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Efficacy: To estimate the overall efficacy of CCT, SMDs were calculated separately 
for each study and pooled by domain regardless of heterogeneity. All cognitive 
outcomes were analysed regardless of classifications as primary or secondary. 
Significance was defined at p<0.05.  
Moderators of efficacy: To potentially explain between-study variability and which 
design elements may moderate observed efficacy, we performed subgroup meta-
analyses for each domain using following moderators discussed in Chapter 1: 
1. CCT types: Multidomain, speed of processing (SOP) training, WM training, 
video games.  
2. CCT practice: delivery, dose, session length, session frequency. 
3. Study design: control condition, nature of blinding, test administration 
(computerised or paper-and-pencil).  
4. Study quality: PEDro score.  
A formal moderator test was performed using the Q-statistic, which is based on a 
mixed effects model with 95% CI, and tests for heterogeneity between sub-groups of 
studies. Under this model, within-subgroup heterogeneity is calculated using random 
effect, whereas between-group heterogeneity is based on fixed-effect model. Based on 
prior practice, between sub-group heterogeneity is defined as p<0.137.  
Planned meta-regression analyses were performed to examine SMDs against dose, 
session length, session frequency and PEDro scores. Only one study38 provided a total 
dose of more than 40 hours and was therefore excluded from dose analyses.  
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2.2.8 Risk of Bias Across Studies and Additional Analyses  
As this review was limited to published results, it is important to test whether 
publication bias or selective reporting of results might have affected the findings. 
Following previous recommendations39, we visually inspected funnel plots based on 
SMDs and standard error for every cognitive domain using CMA, and tested possible 
funnel plots asymmetries using Egger’s Test of the Intercepts40. When possible 
publication bias was detected (1-tailed p<0.1), intercepts and 95% CI were calculated 
using CMA.    
2.3 Results  
2.3.1 Study Selection and Characteristics  
Figure 2.1 presents a flowchart for study selection. Of the 37 studies included in this 
review, 22 were obtained from the original search and 15 were added from our own 
manual search. Overall, the 37 studies encompassed 4,310 participants and provided 
344 effect sizes (see Table 2.1). All studies were randomised controlled trials (RCTs) 
with at least one CCT and one control arm. 30 different CCT programs were 
identified, with doses (i.e., total training time) ranging from 441 to 6042 hours.  
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Figure 2.1: Flow diagram for the search and inclusion of studies in this review  
 
1848 records identified 
through database searching  
1850 records after duplicates removed  
15 additional records identified 
through other sources 
1386 abstracts excluded, mainly due to: 
•  Did not have a CCT intervention or not 
reported empirical results 
•  Not healthy older adults  
•  Not RCT 
•  Published abstracts 
•  Post-training cognitive data reported 
elsewhere   
464 full-text articles 
assessed for eligibility 
431 full-text articles excluded 
•  Did not have a CCT intervention or not 
reported empirical results (n = 175)  
•  Published abstracts or data reported 
elsewhere (n = 99) 
•  Not healthy older adults (n = 78) 
•  Not RCT (n = 52)  
•  Not reporting cognitive endpoints (n = 20) 
•  Authors did not provide data (n = 2) 
37 studies (38 independent 
group comparisons) 
included in the analyses 
Note:&Berry&is&included&in&not&CCT&–&change&in&next&version&
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Table 2.1: Study characteristics              
 Study demographicsa  Intervention design  Study design and quality 
Study name N Age Sexb MMSE 
 
CCT type Delivery Program Dose Sess. Length S/wk 
 
Control Design PEDro 
Ackerman 201043 78 60.7 69   Multidomain Home Wii Big Brain 
Academy 
20 20 60 5  Active Unblinded 3 
Anderson 201344 67 63.0 41.8 27.4  Multidomain Home Posit Brain Fitness 40 40 60 5  Active Assessor-
Blind 
6 
Anguera 201319 31 66.8  ≥26  Video Game Home In-house program 
(‘NeuroRacer’) 
12 12 60 3  Active Subject-
Blind 
6 
Ball 200245 139
8 
73.6  24  27.3  Speed of 
Processing 
Centre Speed of 
Processing 
11 10 67 2  Passive Assessor-
Blind 
9 
Barnes 201346 63 73.9 39.7 28.4 c  Multidomain Home Posit Brain Fitness 
+ Insight 
36 36 60 3  Active Double 9 
Basak 200847 34 69.6 25.7 29.3  Video Game Centre Rise of Nations 24 15 120 3  Passive Unblinded 5 
Boot 201338 41 72.5 39.9 29  Multidomain Home Brain Age 2 
(Nintendo DS) 
60 60 60 5  Passive Unblinded 7 
Bottiroli 200948 44 66.2  27.6  Multidomain Centre Neuropsychological 
Training software  
6 3 90 1  Passive Unblinded 6 
Bozoki 201349 60 68.9 41.6 27.3  Multidomain Home In-house program 
(‘My Better Mind’) 
30 30 60 5  Active Subject-
Blind 
6 
Brehmer 201150 24 63.6 50.0   Working 
memory 
Home Cogmed 10 25 25 5  Active Unblinded 8 
Brehmer 201251 45 63.8 55.4   Working 
memory 
Home Cogmed 9 23 26 4  Active Double 8 
Buschkuehl 200852 39 80.0 41.0   Multidomain Centre In-house program  18 24 45 2  Active Unblinded 5 
Colzato 201134 20 53.3 54.3 28.8  Multidomain Home In-house program 25 50 30 7  Active Unblinded 4 
Dahlin 200853 29 68.3 37.9 28.8  Working 
memory 
Centre In-house program  11 15 45 3  Passive Unblinded 6 
Edwards 200254 97 73.7 43.3   Speed of 
Processing 
Centre Speed of 
Processing 
10 10 60 2  Passive Unblinded 5 
Edwards 200555 126 75.6  28.1  Speed of 
Processing 
Centre Speed of 
Processing 
10 10 60 2  Active Unblinded 6 
Goldstein 199756 22 77.7    Video Game Home Tetris 31     Passive Unblinded 5 
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Table 2.1: Study characteristics              
 Study demographicsa  Intervention design  Study design and quality 
Study name N Age Sexb MMSE 
 
CCT type Delivery Program Dose Sess. Length S/wk 
 
Control Design PEDro 
Lampit 201357 77 72.1 32.2 28.0  Multidomain Centre Cogpack 36 36 60 3  Active Double 9 
Lee 201258 30 0.0 46.7 27.0  Speed of 
Processing 
Centre RehaCom 9 18 30 3  Active Unblinded 4 
Legault 201159 36 75.7 58.5 28.5c  Multidomain 
Working 
memory 
Centre In-house program 18 24 44 2  Active Assessor-
Blind 
8 
Mahncke 200624 123 70.9 50.0 ≥24  Multidomain Home Posit Brain Fitness 
(prototype)  
40 40 60 5  Active Assessor-
Blind 
8 
Maillot 201222 30 73.5  28.0  Multidomain Centre Exergames 
(Nintendo Wii) 
24 24 60 2  Passive Unblinded 5 
McAvinue 201360 36 70.4 36.1 28.1  Working 
memory  
Home In-house program 36 36 60 3  Active Unblinded 3 
Miller 201361 69 81.9 32.3 28.0  Multidomain Home Dakim's Brain 
Fitness 
15 40 23 5  Passive Unblinded 6 
Nouchi 201223 28 69.1  28.5  Multidomain Home Nintendo Brain 
Age 
5 20 15 5  Active Double 8 
Peretz 201162 155 67.8 38.0 29.0  Multidomain Home CogniFt 16 39 25 3  Active Double 10 
Rasmusson 199963 24 79.2  27.8  Multidomain Centre Colorado 
Neuropsychology 
Tests  
14 9 90 1  Passive Unblinded 6 
Richmond 201164 40 66.0 20.0 29.0  Working 
memory 
Home In-house program 10 20 30 4  Active Unblinded 6 
Shatil 201365 64 80.5 32.3 ≥24  Multidomain Centre CogniFit 32 48 40 3  Active Unblinded 5 
Simpson 201266 34 62.3 47.1 ≥27  Multidomain Home mybraintrainer.com 7 21 20 7  Active Unblinded 7 
Smith 200925 487 75.3 47.6 29.2  Multidomain Home Posit Brain Fitness 40 40 60 5  Active Double 10 
Stern 201167 40 66.3 46.0   Video Game Centre Space Fortress 36 36 60 3  Passive Unblinded 8 
van Muijden 201268 72 67.6 55.6 28.8  Multidomain Home In-house program  25 49 30 7  Active Subject-
Blind 
7 
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Table 2.1: Study characteristics              
 Study demographicsa  Intervention design  Study design and quality 
Study name N Age Sexb MMSE 
 
CCT type Delivery Program Dose Sess. Length S/wk 
 
Control Design PEDro 
Vance et al 200769 159 75.1 52.2 28.6  Speed of 
Processing 
Centre Speed of 
Processing 
10 10 60 1  Active Unblinded 4 
von Bastian 201370 57 68.5 59.6 ≥25  Working 
memory 
Home In-house program 16 20 27 5  Active Double 8 
Wang 201141 52 64.2 32.7 28.4  Video Game Centre In-house program 4 5 45 1  Active Subject-
Blind 
6 
Wolinsky 201132 456 61.9 39.1   Speed of 
Processing 
Centre Posit On the Road 10 5 120 1  Active Double 8 
a For the whole sample; b % males; c converted from the Modified Mental State Exam (3MSE, 1-100 scale) to MMSE 1-30 scale, 
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2.3.2 Meta-Analysis of Memory Outcomes   
Efficacy on Memory. Figure 2.2 shows effects for the k = 25 studies comparing 
pretest–posttest gains between CCT and control groups on all memory measures, 
excluding WM (N CCT = 1,654, mean sample size = 66; N controls = 1,614, mean 
sample size = 65). 19 studies reported more than one memory outcomes, which were 
combined into one effect size per study. The combined effect size was small but 
significant (SMD = 0.28, 95% CI [0.09, 0.47], p<0.01). The heterogeneity between 
studies was large and significant, I2 = 78.99%, p<0.01. The funnel plot showed 
considerable asymmetry towards the left of the funnel (Egger’s intercept = 1.23, 95% 
CI [-0.18, 2.63], p=0.04, see Figure 2.3), suggesting possible under-reporting of 
positive outcomes. Table 3.2. presents training efficacy by memory sub-domains.  
 
Figure 2.2: Forest plot for effects on memory based on all studies, rank ordered by SMD. 
 
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Standard Lower Upper 
in means error Variance limit limit p-Value
Barnes et al (2013) Combined -0.236 0.253 0.064 -0.732 0.260 0.350
Boot et al (2013) Combined -0.138 0.321 0.103 -0.767 0.491 0.668
Rasmusson et al (2010)Combined -0.104 0.424 0.180 -0.936 0.728 0.807
Dahlin et al (2008) Combined -0.079 0.375 0.141 -0.814 0.656 0.834
Legault et al (2011) Combined -0.059 0.351 0.123 -0.746 0.628 0.866
Simpson et al (2012) Combined -0.057 0.367 0.135 -0.778 0.663 0.876
Brehmer et al (2012) RAVLT -0.045 0.302 0.091 -0.636 0.547 0.883
Bozoki et al (2013) Combined -0.017 0.259 0.067 -0.525 0.492 0.949
Ball et al (2002) Combined -0.009 0.053 0.003 -0.114 0.096 0.871
Miller et al (2013) Combined 0.034 0.233 0.054 -0.423 0.491 0.885
Vance et al (2007) Combined 0.061 0.159 0.025 -0.251 0.372 0.703
Stern et al (2011) Combined 0.104 0.321 0.103 -0.525 0.734 0.745
Edwards et al (2002) Combined 0.110 0.210 0.044 -0.302 0.522 0.601
Buschkuehl et al (2008)Combined 0.111 0.251 0.063 -0.381 0.602 0.659
Smith et al (2009) Combined 0.142 0.091 0.008 -0.035 0.320 0.117
Mahncke et al (2006) RBANS Gobal Auditory Memory/Attention Score 0.184 0.634 0.402 -1.058 1.426 0.771
Peretz et al (2011) Combined 0.214 0.183 0.034 -0.145 0.574 0.243
Richmond et al (2011) Combined 0.263 0.322 0.104 -0.369 0.895 0.415
Basak et al (2008) Visual STM 0.363 0.323 0.104 -0.270 0.996 0.261
Lampit et al (2013) Combined 0.440 0.233 0.054 -0.017 0.896 0.059
McAvinue et al (2013) Combined 0.527 0.341 0.116 -0.141 1.195 0.122
Brehmer et al (2011) RAVLT 0.561 0.426 0.181 -0.273 1.395 0.187
Shatil (2012) Global Visual Memory 0.726 0.263 0.069 0.211 1.241 0.006
Bottiroli et al (2009) Combined 1.443 0.393 0.154 0.673 2.212 0.000
Anderson et al (2013) Memory for Words (WJ-III Auditory STM) -SS 3.862 0.414 0.171 3.051 4.673 0.000
0.282 0.098 0.010 0.090 0.475 0.004
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours CCT
Meta Analysis
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Figure 2.3: Funnel plot of precision by SMD for studies reporting memory outcomes 
 
Memory 
subomain   
All outcome for 
subdomain  Immediate recall Delayed recall  
Verbal 
memory  
k  20 14 8 
SMD (95% CI) 0.22 (0–0.45)  0.26 (-0.03–0.55)  0.10 (-0.04–0.24)  
I2  80.12%** 86.29%** 4.45% 
Non-verbal 
memory 
k  11 8 5 
SMD (95% CI) 0.37* (0.7–0.66)  0.38* (0.01–0.75)  0.36 (-0.01–0.73)  
I2  75.82%** 79.1%** 65.58%* 
Table 3.2.: Effect sizes for memory subdomains (all studies) 
* p < 0.05. ** p < 0.01.  
 
Moderators of CCT efficacy on memory outcomes. Figure 2.4 presents subgroup 
analysis of memory outcomes by type of CCT. Only multidomain CCT produced 
significant effects of medium size (k=14, SMD = 0.43, 95% CI [0.07, 0.79], p=0.02, 
I2=86.95%, p=0.02). There were no significant effects on memory for SOP training 
(k=3, SMD = 0.004, 95% CI [-0.09, 0.09], p=0.93, I2=0%, p=0.80), video games (k=2, 
SMD = 0.23, 95% CI [-0.21, 0.68], p=0.31, I2=0%, p=0.57) and WM training (k=6, 
SMD = 0.17, 95% CI [-0.10, 0.45], p=0.22, I2=0%, p=0.64).  
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In addition, a significant formal test for moderator effect was found for training type 
(Q(3)=6.46, p=0.09), strong evidence that this has a key influence on memory 
outcomes. Given that non-multidomain types of CCT were ineffective on memory, 
and funnel plot analysis of multidomain studies did not show any significant 
asymmetry (Egger’s intercept = 1.75, 95% CI [-1.53, 5.04], p=0.13), the subsequent 
subgroup analyses were performed solely on RCTs of multidomain CCT (k=14, N 
CCT = 680, mean sample size = 48.57, N controls = 655, mean sample size = 46.79).  
Figure 2.4: Subgroup analysis of memory outcomes by type of CCT 
 
Practice moderators of multidomain CCT efficacy on memory: delivery, dose, 
session length and frequency. Whilst centre-based training produced medium effect 
size (k=5, SMD = 0.50, 95% CI [0.07, 0.93], p=0.02, I2=63.69%, p=0.02), home-
based training was ineffective (k=9, SMD = 0.39, 95% CI [-0.11, 0.89], p=0.13, 
I2=90.53%, p<0.01). However, formal test for between-subgroup heterogeneity was 
non-significant (Q(1)=0.1, p=0.75).  
CCT Type Study name
SMD Lower limit Upper limit p-Value
Multidomain Anderson et al (2013) 3.86 3.05 4.67 0.00
Barnes et al (2013) -0.24 -0.73 0.26 0.35
Boot et al (2013) -0.14 -0.77 0.49 0.67
Bottiroli et al (2009) 1.44 0.67 2.21 0.00
Bozoki et al (2013) -0.02 -0.52 0.49 0.95
Buschkuehl et al (2008) 0.11 -0.38 0.60 0.66
Lampit et al (2013) 0.44 -0.02 0.90 0.06
Mahncke et al (2006) 0.18 -1.06 1.43 0.77
Miller et al (2013) 0.03 -0.42 0.49 0.89
Peretz et al (2011) 0.21 -0.15 0.57 0.24
Rasmusson et al (2010) -0.10 -0.94 0.73 0.81
Shatil (2012) 0.73 0.21 1.24 0.01
Simpson et al (2012) -0.06 -0.78 0.66 0.88
Smith et al (2009) 0.14 -0.04 0.32 0.12
0.43 0.07 0.79 0.02
Ball et al (2002) -0.01 -0.11 0.10 0.87
Edwards et al (2002) 0.11 -0.30 0.52 0.60
Vance et al (2007) 0.06 -0.25 0.37 0.70
0.00 -0.09 0.10 0.93
Video Game Basak et al (2008) 0.36 -0.27 1.00 0.26
Stern et al (2011) 0.10 -0.53 0.73 0.75
0.23 -0.21 0.68 0.31
Working Memory Brehmer et al (2011) 0.56 -0.27 1.39 0.19
Brehmer et al (2012) -0.04 -0.64 0.55 0.88
Dahlin et al (2008) -0.08 -0.81 0.66 0.83
Legault et al (2011) -0.06 -0.75 0.63 0.87
McAvinue et al (2013) 0.53 -0.14 1.20 0.12
Richmond et al (2011) 0.26 -0.37 0.89 0.42
0.17 -0.10 0.45 0.22
Overall 0.05 -0.03 0.14 0.22
Statistics for each study Std$diff$in$means$and$95%$CI
Speed of 
Processing
All Working Memory studies
All Video Game studies
All Speed of Processing studies
All Multidomain studies
Group by
CCT class
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Multidomain Anderson et al (2013) W-J III Auditory ST memory 3.86 3.05 4.67 0.00
Multidomain Barnes et al (2013) Combined -0.24 -0 73 0.26 0.35
Multidomain Boot et al (2013) Combi d -0.14 7 0.49 0.67
Multidomain Bottiroli et al (2009) Combined 1.44 .6 2.21 0.00
Multidomain Bozoki et al (2013) Combined -0.02 - 52 0.49 0.95
Multidomain Buschkuehl et al (2008)Combined 0.11 - .38 0.60 0.66
Multidomain Lampit et al (2013) Combined 0.44 - .02 0.90 0.06
Multidomain Mahncke et al (2006) RBANS Auditory Memory/Attention 0.18 1 6 1.43 0.77
Multidomain Miller et al (2013) Combined 0.03 0 42 0.49 0.89
Multidomain Peretz et al (2011) Combined 0.21 -0.15 0.57 0.24
Multidomain Rasmusson et al (2010)Combined -0.10 -0.94 0.73 0.81
Multidomain Shatil (2012) Global Visual Memory 0.73 0.21 1.24 0.01
Multidomain Simpson et al (2012) Combined -0.06 -0.78 0.66 0.88
Multidomain Smith et al (2009) Combined 0.14 -0.04 0.32 0.12
Multidomain 0.43 0.07 0.79 0.02
Speed of Processing Ball et al (2002) Combin d -0.01 - . 0.10 0.87
Speed of Processing Edwards et al (2002) Combine 0.11 - . 0.52 0.60
Speed of Processing Vance et al (2007) Combined 0.06 -0.25 0.37 0.70
Speed of Processing 0.00 -0.09 0.10 0.93
Video Game Basak et al (2008) Visual STM 0.36 -0.27 1.00 0.26
Video Game Stern et al (2011) Combined 0.10 -0.53 0.73 0.75
Video Game 0.23 -0.21 0.68 0.31
Working Memory Brehmer et al (2011) RAVLT 0.56 - . 1.39 0.19
Working Memory Brehmer et al (2012) RAVLT -0.04 0.55 0.88
Working Memory Dahlin et al (2008) Combined -0.08 0.66 0.83
Working Memory Legault et al (2011) Combined -0.06 0.63 0.87
Working Memory McAvinue et al (2013) Combined 0.53 1.20 0.12
Working Memory Richmond et al (2011) Combined 0.26 - . 0.89 0.42
Working Memory 0.17 0.45 0.22
Overall 0.05 -0.03 0.14 0.22
-2.00 -1.00 0.00 1.00 2.00
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A total training dose of 21-40 hours produced large and significant effect sizes (k=7, 
SMD = 0.68, 95% CI [0.01, 1.35], p=0.04, I2=93.03%, p<0.01), whereas smaller 
doses were ineffective (k=6, SMD = 0.23, 95% CI [-0.11, 0.58], p=0.18, I2=57.15%, 
p=0.04), but again between-subgroups heterogeneity test did not reach statistical 
significance (Q(1)=1.375, p=0.24).  
An analysis of session length was not attempted due a disproportional distribution of 
studies with 30-60 minute sessions (k=9) compared to <30 and >60 minute (k=3 and 
2, respectively). A subgroup analysis of session frequency did not find any 
moderating effect (>3 sessions/wk: k=7, SMD = 0.54, 95% CI [-0.17, 1.25], p=0.14, 
I2=92.64%, p<0.01; 2-3 sessions/wk: k=5, SMD = 0.25, 95% CI [-0.04, 0.54], p=0.09, 
I2=49.17%, p=0.09; 1 session/wk: k=2, SMD = 0.68, 95% CI [-0.84, 2.19], p=0.38, 
I2=86.06%, p<0.01; between-subgroup (Q(2)=0.804, p=0.69). Similarly, meta-
regressions examining memory SMDs against dose, session length and frequency did 
not yield any significant results (data not reported here).  
Study design moderators of multidomain CCT efficacy on memory: control 
condition, blinding and type of outcomes. Studies that compared CCT to active 
control yielded significant results (k=10, SMD = 0.49, 95% CI [0.04, 0.93], p=0.03, 
I2=89.7%, p<0.01), whereas comparison to no-contact control groups did not show an 
effect (k=4, SMD = 0.18, 95% CI [-.36, 0.92], p=0.39, I2=75.31%, p<0.01), but the 
difference did not reach statistical significance when tested for between-subgroup 
heterogeneity (Q(1)=0.27, p=0.61).  
The moderating effect of blinding was tested after excluding the only two single-
blinded studies44,49, leaving a total number of 12 studies. Double-blinded studies 
showed statistically significant, albeit small effects (k=5, SMD = 0.15, 95% CI [0.01, 
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0.29], p=0.04, I2=0.39%, p=0.4), whereas unblinded studies yielded statistically 
insignificant effects (k=7, SMD = 0.28, 95% CI [-0.1, 0.66], p=0.15, I2=63.71%, 
p=0.01). There was no evidence of between-subgroup heterogeneity (Q(1)=0.34, 
p=0.56).  
Memory outcomes based on computerised tests were statistically significant (k=7, 
SMD = 0.37, 95% CI [0.06, 0.67], p=0.02, I2=61.28%, p=0.02), whereas non-
computerised tests did not reach significance (k=9, SMD = 0.38, 95% CI [-0.17, 
0.93], p=0.18, I2=90.55%, p<0.01), yet test for between subgroup heterogeneity was 
insignificant (Q(1)=0.002, p=0.97).  
Study quality moderators of multidomain CCT efficacy on memory. A meta-
regression analysis found a small but statistically insignificant inverse relationship 
between study quality and memory SMDs (b=-0.14, Q(1)=1.45, p=0.22.  
2.3.3 Meta-Analysis of Working Memory Outcomes   
Training effects. Figure 2.5 shows the k= 23 studies comparing pretest–posttest gains 
between CCT and control groups on all WM measures (N CCT = 888, mean sample 
size = 38.61, N controls = 831, mean sample size = 36.13). 18 studies reported more 
than one WM outcomes, which were combined into one effect size per study using 
CMD. The combined effect size was small and statistically significant (SMD = 0.26, 
95% CI [0.07, 0.46], p=0.01). The heterogeneity between studies was medium- to-
large and significant, I2 = 70.99%, p<0.01. The funnel plot did not show significant 
asymmetry (Egger’s intercept = -0.22, 95% CI [-2.17, 1.73], p=0.41).  
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Figure 2.5: Forest plot for effects on working memory (all studies), rank ordered by SMD  
 
Moderating effect of CCT type on working memory outcomes. Only multidomain 
CCT produced statistically significant effects of small size (k=10, SMD = 0.26, 95% 
CI [0.09, 0.43], p<0.01, I2=30.05%, p=0.17). Overall, there were no significant effects 
on working memory outcomes for WM training (k=7, SMD = 0.17, 95% CI [-0.20, 
0.54], p=0.37, I2=54.98%, p=0.04), video game training (k=4, SMD = 0.08, 95% CI [-
0.29, 0.44], p=0.68, I2=0%, p=0.37) or SOP training (k=2, SMD = 0.87, 95% CI [-
0.85, 2.60], p=0.32, I2=96%, p=0<0.01). However, there was no formal evidence of 
heterogeneity between the five types of CCT (Q(3)=1.39, p=0.71) or between the two 
most prevalent subtypes (multidomain and WM training): Q(1)=0.19, p=0.66). The 
remaining subgroup analyses were therefore performed for all CCT studies reporting 
WM outcomes.   
Practice moderators of  CCT efficacy on working memory: delivery, dose, 
session length and frequency. Whilst home-based training produced small but 
statistically significant effect size (k=13, SMD = 0.24, 95% CI [0.06, 0.41], p<0.01, 
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Richmond et al (2011) Combined -0.58 -1.21 0.06 0.08
Stern et al (2011) Letter Number Sequence (WAIS-III) -0.37 -1.00 0.25 0.24
Bozoki et al (2013) 1-Back (WM) -0.27 -0.78 0.24 0.30
Dahlin et al (2008) Combined -0.11 -0.85 0.62 0.76
Legault et al (2011) Combined -0.09 -0.78 0.60 0.80
Basak et al (2008) Combined -0.04 -0.70 0.61 0.89
Edwards et al (2002) Digit Span (WAIS-R Scaled Fwd+Back) -0.00 -0.42 0.41 0.98
von Bastian et al (2013)Combined 0.04 -0.49 0.57 0.88
Simpson et al (2012) Combined 0.05 -0.67 0.77 0.89
Shatil (2012) Auditory (non-linguistic) Working Memory 0.05 -0.44 0.55 0.83
Nouchi et al (2012) Combined 0.06 -0.68 0.80 0.88
van Muijden et al (2012)Combined 0.19 -0.33 0.72 0.47
Wang et al (2011) Combined 0.21 -0.33 0.76 0.45
Smith et al (2009) Combined 0.24 0.06 0.42 0.01
Maillot et al (2012) Combined 0.30 -0.40 0.99 0.40
Peretz et al (2011) Visuospatial Working Memory 0.42 0.05 0.78 0.02
Mahncke et al (2006) Digit span forward 0.42 0.01 0.84 0.04
McAvinue et al (2013) Combined 0.55 -0.12 1.22 0.11
Anguera et al (2013) Combined 0.58 -0.14 1.30 0.12
Brehmer et al (2011) Combined 0.62 -0.22 1.47 0.15
Brehmer et al (2012) Combined 0.84 0.21 1.46 0.01
Buschkuehl et al (2008)Combined 0.92 0.39 1.44 0.00
Edwards et al (2005) Combined 1.76 1.29 2.22 0.00
0.26 0.07 0.46 0.01
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours CCT
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I2=36.28%, p=0.09), centre-based training was ineffective (k=10, SMD = 0.28, 95% 
CI [-0.16, 0.72], p=0.21, I2=83.26%, p<0.01). Formal test for between-subgroup 
heterogeneity was non-significant (Q(1)=0.03, p=0.87).  
A total training dose of 20 hours or less was sufficient to produced small-medium 
effect sizes (k=14, SMD = 0.35, 95% CI [0.02, 0.68], p=0.04, I2=78.09%, p<0.01), 
whereas studies that provided a dose of 21-40 hours showed considerably smaller and 
insignificant effects (k=9, SMD = 0.16, 95% CI [-0.01, 0.33], p=0.06, I2=17.3%, 
p=0.29), but again between-groups heterogeneity did not reach statistical significance 
(Q(1)=1.041, p=0.31).  
Studies with session length of 30-60 minutes showed significant results (k=14, SMD 
= 0.31, 95% CI [0.02, 0.59], p=0.03, I2=78.26%, p<0.01), whereas shorter sessions 
were ineffective (k=8, SMD = 0.21, 95% CI [-0.07, 0.49], p=0.14, I2=44.26%, p=0.08; 
between-subgroup Q(1)=0.244, p=0.62). A subgroup analysis of session frequency 
was performed after removing a single study that used one weekly session41. Studies 
with 2-3 weekly sessions (k=12, SMD = 0.34, 95% CI [-0.01, 0.99], p=0.06, 
I2=79.71%, p<0.01) tended to be more effective than 3 or more sessions per week 
(k=10, SMD = 0.16, 95% CI [-0.05, 0.37], p=0.12, I2=43.44%, p=0.07), albeit 
between-subgroup heterogeneity was not evident (Q(1)=0.71, p=0.40). Meta-
regressions plotting WM SMDs against dose, session length and frequency did not 
yield any significant results (data not shown).  
Study design moderators of CCT efficacy on working memory: control 
condition, blinding and type of outcomes. Studies that compared CCT to active 
control yielded significant results (k=18, SMD = 0.34, 95% CI [0.11, 0.57], p<0.01, 
I2=73.74%, p<0.01), whereas comparison to no-contact control groups did not show 
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an effect (k=5, SMD = -0.05, 95% CI [-.30, 0.21], p=0.73, I2=0%, p=0.73). For this 
moderating factor, significant between- subgroup heterogeneity was found 
(Q(1)=4.82, p=0.03, see Figure 2.6).  
 
Figure 2.6: Forest plot for effects on working memory by control condition  
 
The moderating effect of blinding was tested in only 22 studies, as only one study was 
assessor-blinded59. Only double-blinded studies showed statistically significant results 
(k=6, SMD = 0.30, 95% CI [0.15, 0.45], p<0.01, I2=7.41%, p=0.37), whereas 
insignificant effects were noted for both subject-blind (k=4, SMD = 0.13, 95% CI [-
0.19, 0.45], p=0.43, I2=25.5%, p=0.26) and unblinded studies (k=12, SMD = 0.27, 
95% CI [-0.13, 0.68], p=0.19, I2=82.09%, p<0.01). There was no strong evidence of 
between-subgroup heterogeneity (Q(2)=0.89, p=0.64).  
As opposed to memory outcomes, WM outcomes from computerised tests did not 
reach statistical significance (k=9, SMD = 0.28, 95% CI [-0.06, 0.61], p=0.10, 
Control Study name
SMD Lower limit Upper limit p-Value
Active Richmond et al (2011) -0.58 -1.21 0.06 0.08
Bozoki et al (2013) -0.27 -0.78 0.24 0.30
Legault et al (2011) -0.09 -0.78 0.60 0.80
von Bastian et al (2013) 0.04 -0.49 0.57 0.88
Simpson et al (2012) 0.05 -0.67 0.77 0.89
Shatil (2012) 0.05 -0.44 0.55 0.83
Nouchi et al (2012) 0.06 -0.68 0.80 0.88
van Muijden et al (2012) 0.19 -0.33 0.72 0.47
Wang et al (2011) 0.21 -0.33 0.76 0.45
Smith et al (2009) 0.24 0.06 0.42 0.01
Peretz et al (2011) 0.42 0.05 0.78 0.02
Mahncke et al (2006) 0.42 0.01 0.84 0.04
McAvinue et al (2013) 0.55 -0.12 1.22 0.11
Anguera et al (2013) 0.58 -0.14 1.30 0.12
Brehmer et al (2011) 0.62 -0.22 1.47 0.15
Brehmer et al (2012) 0.84 0.21 1.46 0.01
Buschkuehl et al (2008) 0.92 0.39 1.44 0.00
Edwards et al (2005) 1.76 1.29 2.22 0.00
All active controlled studies 0.34 0.11 0.57 0.00
Passive Stern et al (2011) -0.37 -1.00 0.25 0.24
Dahlin et al (2008) -0.11 -0.85 0.62 0.76
Basak et al (2008) -0.04 -0.70 0.61 0.89
Edwards et al (2002) 0.00 -0.42 0.41 0.98
Maillot et al (2012) 0.30 -0.40 0.99 0.40
All passive controlled studies -0.05 -0.31 0.21 0.73
Overall 0.17 0.00 0.35 0.05
Statistics for each study Std$diff$in$means$and$95%$CI
Group by
Control
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Active Richmond et al (2011) Combined -0.58 -1.21 0.06 0.08
Active Bozoki et al (2013) 1-Back (WM) -0.27 -0.78 0.24 0.30
Active Legault et al (2011) Combined -0.09 -0.78 0.60 0.80
Active von Bastian et al (2013)Combined 0.04 -0.49 0.57 0.88
Active Simpson et al (2012) Combined 0.05 -0.67 0.77 0.89
Active Shatil (2012) Auditory (non-linguistic) Working Memory 0.05 -0.44 0.55 0.83
Active Nouchi et al (2012) Combined 0.06 -0.68 0.80 0.88
Active van Muijden et al (2012)Combined 0.19 -0.33 0.72 0.47
Active Wang et al (2011) Combined 0.21 -0.33 0.76 0.45
Active Smith et al (2009) Combined 0.24 0.06 0.42 0.01
Active Peretz et al (2011) Visuospatial Working Memory 0.42 0.05 0.78 0.02
Active Mahncke et al (2006) Digit span forward 0.42 0.01 0.84 0.04
Active McAvinue et al (2013) Combined 0.55 -0.12 1.22 0.11
Active Anguera et al (2013) Combined 0.58 -0.14 1.30 0.12
Active Brehmer et al (2011) Combined 0.62 -0.22 1.47 0.15
Active Brehmer et al (2012) Combined 0.84 0.21 1.46 0.01
Active Buschkuehl et al (2008)Combined 0.92 0.39 1.44 0.00
Active Edwards et al (2005) Combined 1.76 1.29 2.22 0.00
Active 0.34 0.11 0.57 0.00
Passive Stern et al (2011) Letter Number Sequence (WAIS-III) -0.37 -1.00 0.25 0.24
Passive Dahlin et al (2008) Combined -0.11 -0.85 0.62 0.76
Passive Basak et al (2008) Combined -0.04 -0.70 0.61 0.89
Passive Edwards et al (2002) Digit Span (WAIS-R Scaled Fwd+Back) -0.00 -0.42 0.41 0.98
Passive Maillot et al (2012) Combined 0.30 -0.40 0.99 0.40
Passive -0.05 -0.31 0.21 0.73
Overall 0.17 -0.00 0.35 0.05
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours CCT
Meta Analysis
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I2=70.97%, p<0.01), whereas non-computerised tests did reach significance with a 
small effect size (k=16, SMD = 0.29, 95% CI [0.02, 0.54], p=0.03, I2=74.61%, 
p<0.01), but test for heterogeneity was insignificant as well (Q(1)=0.003, p=0.96).  
Study quality moderators of all-type CCT efficacy on working memory. A meta-
regression analysis did not find any relationship between study quality and WM 
outcomes speed SMDs (β =0.04, Q(1)=0.27, p=0.61).  
2.3.4 Meta-Analysis of Processing Speed Outcomes    
Efficacy. Figure 2.7 shows the k =23 studies comparing pretest–posttest gains 
between CCT and control groups on all processing speed measures (N CCT = 1,615, 
mean sample size = 70.22, N controls = 1,456, mean sample size = 63.30). 19 studies 
reported two or more processing speed outcomes, which were combined into one 
effect size per study. Two studies32,45 reported UFOV sub-scores as well as a 
composite score, and only the latter was included in the analyses. The combined 
effect size was medium-sized and significant (SMD = 0.40, 95% CI [0.18, 0.63], 
p<0.01). Heterogeneity between studies was large and significant, I2 = 83.21%, 
p<0.01. The funnel plot did not show any significant asymmetry (Egger’s intercept = 
-0.41, 95% CI [-2.16, 1.34], p=0.31).  
Moderating effect of CCT types on processing speed outcomes. Statistically 
significant medium-size effects were noted for studies involving SOP training (k=5, 
SMD = 0.49, 95% CI [0.31, 0.67], p<0.01, I2=61.56%, p=0.03) and video games (k=4, 
SMD = 0.44, 95% CI [0.07, 0.80], p=0.02, I2=16.49%, p=0.31). Multidomain training 
did not show statistically significant effects (k=13, SMD = 0.35, 95% CI [-0.16, 0.87], 
p=0.18, I2=89.19%, p=0.17), and neither did the single study of WM training  (SMD 
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= 0.37, 95% CI [-0.37, 1.10], p=0.33). No significant between-subgroup 
heterogeneity was observed (Q(3)=0.35, p=0.95), and hence the remaining of analyses 
were performed on all studies reporting processing speed outcomes. 
 
Figure 2.7: Forest plot for effects on processing speed (all studies), rank ordered by SMD  
 
Practice moderators of all-type CCT efficacy on processing speed: delivery, dose, 
session length and frequency. Only centre-based training produced statistically 
significant effect (k=11, SMD = 0.46, 95% CI [0.34, 0.59], p<0.01, I2=29.67%, 
p=0.16). Home-based training was ineffective (k=12, SMD = 0.40, 95% CI [-0.20, 
1.00], p=0.19, I2=90.17%, p<0.01), but a formal test for between-subgroup 
heterogeneity was non-significant (Q(1)=0.04, p=0.85).  
A total training dose of 20 hours or less produced significant effects (k=11, SMD = 
0.41, 95% CI [0.23, 0.58], p<0.01, I2=57.79%, p<0.01), whereas studies that provided 
a dose of 21-40 hours showed insignificant results (k=11, SMD = 0.48, 95% CI [-
0.13, 1.09], p=0.21, I2=90.28%, p<0.01), but between-subgroups heterogeneity did 
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Colzato et al (2011) Met Combined -1.73 -2.76 -0.70 0.00
Ackerman et al (2010) Combined -0.29 -0.74 0.16 0.20
van Muijden et al (2012) Combined -0.25 -0.78 0.28 0.36
Boot et al (2013) Combined -0.19 -0.81 0.44 0.56
Colzato et al (2011) Val/ValCombined -0.11 -1.00 0.78 0.81
Edwards et al (2002) Combined 0.16 -0.26 0.57 0.46
Barnes et al (2013) Combined 0.16 -0.34 0.65 0.54
Wang et al (2011) Combined 0.21 -0.33 0.76 0.44
Lampit et al (2013) Inoformation Processing Speed 0.23 -0.23 0.68 0.32
Maillot et al (2012) Combined 0.32 -0.45 1.09 0.41
Bozoki et al (2013) Combined 0.33 -0.18 0.84 0.20
Stern et al (2011) Digit Symbol (WAIS-III) 0.34 -0.28 0.96 0.28
Dahlin et al (2008) Digit Symbol Substitution 0.37 -0.37 1.10 0.33
Wolinsky et al (2011) UFOV Composite 0.37 0.18 0.56 0.00
Anguera et al (2013) Combined 0.39 -0.32 1.10 0.28
Edwards et al (2005) Combined 0.44 0.08 0.81 0.02
Ball et al (2002) Combined 0.54 0.43 0.64 0.00
Simpson et al (2012) Combined 0.54 -0.21 1.29 0.16
Shatil (2012) Combined 0.75 0.23 1.26 0.00
Nouchi et al (2012) Combined 0.79 0.01 1.56 0.05
Vance et al (2007) Combined 0.90 0.56 1.24 0.00
Goldstein et al (1997) Reaction time 1.22 0.31 2.14 0.01
Anderson et al (2013) WJ-III Visual Matching 4.03 3.20 4.87 0.00
0.45 0.38 0.52 0.00
-2.00 -1.00 0.00 1.00 2.00
Favours Cotrol Favours CCT
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not reach statistical significance (Q(1)=1.05, p=0.81). A subgroup analysis of session 
length was not attempted due to a disproportional number of studies with 30-60 
minutes per session (k=15) compared to less than 30 minutes (k=5) and more than 60 
minutes (k=3).  
Studies with 2-3 weekly sessions were effective on processing speed (k=10, SMD = 
0.48, 95% CI [0.39, 0.57], p<0.06, I2=0%, p=0.56), and so were studies with only one 
session per week (k=3, SMD = 0.51, 95% CI [0.12, 0.91], p=0.01, I2=75.56%, 
p=0.02), but more than 3 sessions per week was not effective (k=10, SMD = 0.43, 
95% CI [-0.32, 1.18], p=0.26, I2=91.94%, p<0.01). Between-subgroup heterogeneity 
was insignificant among the three frequency categories (Q(2)=0.04, p=0.98) as well 
as between 2-3 and >3 weekly sessions (Q(1)=0.02, p=0.90). Meta-regressions 
plotting processing speed SMDs against dose, session length and frequency did not 
find any significant results (data not reported here).  
Study design moderators of all-type CCT efficacy on processing speed: control 
condition, blinding and type of outcomes. Significant effects were noted for studies 
comparing CCT to both active control (k=16, SMD = 0.42, 95% CI [0.08, 0.77], 
p=0.01, I2=87.39%, p<0.01) and no-contact control conditions (k=7, SMD = 0.37, 
95% CI [0.12, 0.62], p<0.01, I2=43.83%, p=0.1). A significant between-group 
heterogeneity was not found (Q(1)=0.06, p=0.81). The moderating effect of blinding 
was not tested due to disproportionally large number of unblended studies (k=13) 
compared to studies with subject-blinded (k=4), assessor-blinded (k=4) and double-
blinded (k=2) designs.  
Effect sizes on processing were similar and statistically significant for both 
computerised tests (k=17, SMD = 0.33, 95% CI [0.03, 0.62], p=0.03, I2=89.43%, 
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p<0.01), and non-computerised tests (k=14, SMD = 0.40, 95% CI [0.04, 0.75], 
p=0.03, I2=88.66%, p<0.01) with insignificant heterogeneity (Q(1)=0.09, p=0.76).  
Study quality moderators of all-type CCT efficacy on processing speed. A meta-
regression analysis did not find any relationship between study quality and WM 
SMDs (b=0.03, Q(1)=0.18, p=0.67).  
2.3.5 Meta-Analysis of Attention Outcomes    
Efficacy. Figure 2.8 shows the 10 effect sizes comparing pretest–posttest gains 
between CCT and control groups on all attention measures (N CCT = 367, mean 
sample size = 36.7, N controls = 302, mean sample size = 30.2). 6 studies reported 
two or more attention outcomes, which were combined into one effect size per study. 
The combined effect size was small (SMD = 0.26, 95% CI [0.005, 0.517], p=0.046). 
The heterogeneity between studies was medium-sized and significant, I2 = 58.62%, 
p=0.01. The funnel plot showed a possible albeit not significant asymmetry towards 
to the left of the funnel (Egger’s intercept = 2.23, 95% CI [-1.37, 5.83], p=0.1).  
 
Figure 2.8: Forest plot for effects on attention (all studies), rank ordered by SMD  
 
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Richmond et al (2011) TEA - Elevator Counting with Reversal -0.46 -1.09 0.17 0.15
Basak et al (2008) Combined -0.06 -0.69 0.57 0.84
Peretz et al (2011) Combined -0.06 -0.41 0.30 0.76
Vance et al (2007) PASAT (/83) -0.01 -0.33 0.30 0.93
Anguera et al (2013) Combined 0.27 -0.44 0.98 0.46
van Muijden et al (2012)Combined 0.30 -0.22 0.83 0.26
Lampit et al (2013) Attention Mean 0.47 0.02 0.92 0.04
Shatil (2012) Combined 0.73 0.21 1.24 0.01
Brehmer et al (2012) PASAT 0.80 0.19 1.42 0.01
Brehmer et al (2011) PASAT 1.06 0.19 1.93 0.02
0.26 0.00 0.52 0.05
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Moderating effect of CCT types on attention outcomes. Possibly due to the small 
number of studies reporting attention outcomes, none of the interventions reached the 
significance threshold, but multidomain training showed a small effect with trend 
towards significance (k=4, SMD = 0.33, 95% CI [-0.02, 0.68], p=0.06, I2=57.09%, 
p=0.07). There was no evidence for efficacy for WM training (k=3, SMD = 0.44, 
95% CI [-0.5, 1.39], p=0.36, I2=81.85%, p<0.01) or video games (k=2, SMD = 0.08, 
95% CI [-0.39, 0.55], p=0.73, I2=0%, p=0.49). A single study69 reported a null effect 
of SOP training on attention (SMD = -0.01, 95% CI [-0.33, 0.30], p=0.93). No 
significant between-group heterogeneity was observed (Q(3)=2.57, p=0.46), and thus 
the following analyses were performed on all studies reporting attention outcomes. 
Practice moderators of CCT efficacy on attention: delivery, dose, session length 
and frequency. Neither centre-based training (k=4, SMD = 0.27, 95% CI [-0.1, 0.65], 
p=0.15, I2=61.95%, p=0.05) nor home-based training (k=6, SMD = 0.26, 95% CI [-
0.13, 0.66], p=0.19, I2=63. 57%, p=0.02) produced significant effects. A total training 
dose of 21-40 hours showed medium effect size (k=4, SMD = 0.40, 95% CI [0.10, 
0.69], p<0.01, I2=22.45%, p=0.28), whereas studies that provided a dose of 20 hours 
or less showed insignificant results (k=6, SMD = 0.19, 95% CI [-0.17, 0.55], p=0.31, 
I2=64.76%, p=0.01), but between-subgroups heterogeneity did not reach statistical 
significance (Q(1)=0.76, p=0.38).  
A subgroup analysis of session frequency was performed after removing the single 
study that used session length of more than 60 minutes47. Studies with 30-60 minutes 
per session showed trend towards significance (k=4, SMD = 0.33, 95% CI [-0.03, 
0.69], p=0.07, I2=57.16%, p=0.07) and studies with session length of 30 minutes or 
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less were ineffective (k=5, SMD = 0.27, 95% CI [-0.2, 0.74], p=0.25, I2=70.85%, 
p<0.01). Between-subgroup heterogeneity was not evident (Q(1)=0.04, p=0.84).     
A subgroup analysis of session length was performed after removing the single study 
that used only one weekly session69. Non-significant results were noted for both 2-3 
weekly sessions (k=5, SMD = 0.26, 95% CI [-0.06, 0.6], p=0.11, I2=49.9%, p=0.1) 
and more than 3 sessions per week (k=4, SMD = 0.39, 95% CI [-0.23, 1.01], p=0.214, 
I2=72.86%, p=0.01), and between-subgroup heterogeneity was insignificant 
(Q(1)=0.13, p=0.72) Meta-regressions plotting attention SMDs against dose, session 
length and frequency did not find any significant results (data not shown).  
Study design moderators of all-type CCT efficacy on attention: control 
condition, blinding and type of outcomes. A subgroup analyses of control condition 
was not performed as only one study47 used a no-contact control group. None of the 
blinding conditions showed significant results (unblinded k=5, SMD = 0.21, 95% CI 
[-0.26, 0.67], p=0.38, I2=71.71%, p<0.01; double-blinded k=3, SMD = 0.36, 95% CI 
[-0.14, 0.86], p=0.16, I2=70.72%, p=0.03; subject-blinded k=2, SMD = 0.29, 95% CI 
[-0.13, 0.71], p=0.18, I2=0%, p=0.94) and there was no between-subgroup 
heterogeneity (Q(2)=0.2, p=0.9).  
Effect sizes on attention were significant only for computerised tests, which also 
showed low within-subgroup heterogeneity (k=6, SMD = 0.27, 95% CI [0.003, 0.53], 
p=0.05, I2=37.43%, p=0.15). Effects on non-computerised tests were insignificant 
(k=4, SMD = 0.29, 95% CI [-0.31, 0.89], p=0.34, I2=77.26%, p<0.01), but a formal 
test for between-subgroup heterogeneity was insignificant (Q(1)=0.005, p=0.95).  
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Study quality moderators of all-type CCT efficacy on attention. A meta-
regression analysis did not find any relationship between study quality and attention 
SMDs (b=0.04, Q(1)=0.33, p=0.56).  
2.3.6 Meta-Analysis of Language Outcomes    
Efficacy. Figure 2.9 shows the k=7 studies comparing pretest–posttest gains between 
CCT and control groups on all language measures (N CCT = 218, mean sample size = 
31.14, N controls = 214, mean sample size = 30.57). Four studies reported two or 
more language outcomes, which were combined into one effect size per study. The 
combined effect size was medium (SMD = 0.47, 95% CI [0.02, 0.92], p=0.04). The 
heterogeneity between studies was large and significant, I2 = 81.0%, p<0.01. The 
funnel plot did not show evidence of asymmetry (Egger’s intercept = -0.94, 95% CI [-
17.00, 15.10], p=0.44).  
 
Figure 2.9: Forest plot for effects on language (all studies), rank ordered by SMD  
 
Moderating effect of CCT types on language outcomes. A subgroup analysis of 
CCT types was not possible as four of the seven studies used multidomain programs 
and there were only single reports for SOP training54, video games67 and WM 
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Lampit et al (2013) Combined -0.07 -0.53 0.39 0.77
Stern et al (2011) Category Fluency 0.18 -0.44 0.80 0.57
Barnes et al (2013) Combined 0.18 -0.31 0.68 0.47
Miller et al (2013) Combined 0.18 -0.27 0.64 0.43
Dahlin et al (2008) Combined 0.43 -0.31 1.17 0.26
Shatil (2012) Naming 0.78 0.26 1.30 0.00
Edwards et al (2002) COWAT 1.58 1.11 2.05 0.00
0.47 0.02 0.92 0.04
-1.00 -0.50 0.00 0.50 1.00
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training53. The rest of the subgroup analyses were therefore attempted using all studies 
reporting language outcomes. 
Practice moderators of all-type CCT efficacy on language: delivery, dose, session 
length and frequency. A subgroup analysis of delivery was not performed due to a 
disproportionally large of centre-based CCT studies (k=5) compared to studies of 
home-based CCT (k=2). A subgroup analysis of training dose did not find any 
significant effects for either 20 hours or less (k=3, SMD = 0.74, 95% CI [-0.21, 1.69], 
p=0.12, I2=89.16%, p<0.01) or 20-40 hours (k=4, SMD = 0.26, 95% CI [-0.10, 0.63], 
p=0.16, I2=50.0%, p=0.11). A subgroup analysis of session duration was not 
performed as only one study61 used 20-25 minutes per sessions, whereas all the other 
studies had a session length of 30-60 minutes. Similarly, the same study61 was the 
only one to include more than three weekly sessions, and since all the other studies 
used a session frequency of 2-3 sessions per week, a subgroup analysis could not be 
performed. A series meta-regressions examining language SMDs against dose, 
session length and frequency did not find any significant results (data not shown).  
Study design moderators of all-type CCT efficacy on language: control 
condition, blinding and type of outcomes. No significant effects were noted from 
either active-controlled (k=3, SMD = 0.29, 95% CI [-0.20, 0.78], p=0.25, I2=66.29%, 
p=0.05) or no-contact control studies (k=4, SMD = 0.60, 95% CI [-0.14, 1.35], 
p=0.11, I2=86.03%, p<0.01).     
A subgroup analysis of blinding condition found a significant between-subgroup 
heterogeneity (Q(1)=3.13, p=0.08, see Figure 2.10) between unblinded designs (k=5, 
SMD = 0.65, 95% CI [0.08, 1.21], p=0.03, I2=81.48%, p<0.01) and double-blinded 
studies (k=2, SMD = 0.18, 95% CI [-0.31, 0.68], p=0.47, I2=0%, p=0.46). A subgroup 
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analysis of computerised testing was not performed as only one study65 used a 
computerised language test. 
 
Figure 2.10: Forest plot for CCT effects on language by blinding condition  
 
Study quality moderators of all-type CCT efficacy on language. A meta-
regression analysis found a significant inverse relationship between language SMDs 
and PEDro scores (b=-0.24, Q(1)=5.76, p=0.02, see Figure 2.11).  
 
Figure 2.11: Meta-regression of PEDro scores on language SMDs. Note: circle diameters are 
proportional to sample size  
 
Design Study name
SMD Lower limit Upper limit p-Value
Double-blind Lampit et al (2013) -0.07 -0.53 0.39 0.77
Barnes et al (2013) 0.18 -0.31 0.68 0.47
All double-blinded studies 0.18 -0.31 0.68 0.47
Unblinded Stern et al (2011) 0.18 -0.44 0.80 0.57
Miller et al (2013) 0.18 -0.27 0.64 0.43
Dahlin et al (2008) 0.43 -0.31 1.17 0.26
Shatil (2012) 0.78 0.26 1.30 0.00
Edwards et al (2002) 1.58 1.11 2.05 0.00
All unblinded studies 0.65 0.08 1.21 0.03
Overall 0.20 -0.09 0.49 0.17
Statistics for each study Std$diff$in$means$and$95%$CIGroup byDesign
Study name Outcome Statistics for each study Sample size Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value CCT Control
Double Lampit et al (2013) Combined -0.07 -0.53 0.39 0.77 39 34
Double Barnes et al (2013) Combined 0.18 -0.31 .68 0.47 31 32
Double 0.05 -0.29 . 9 0.78 70 66
Unblinded Stern et al (2011) Category Fluency 0.18 -0.44 .80 0.57 20 20
Unblinded Miller et al (2013) Combined 0.18 -0.27 .64 0.43 38 36
Unblinded Dahlin et al (2008) Combined 0.43 -0.31 1.17 0.26 13 16
Unblinded Shatil (2012) Naming 0.78 0.26 1.30 0.00 33 29
Unblinded Edwards et al (2002)COWAT 1.58 1.11 2.05 0.00 44 47
Unblinded 0.65 0.08 1.21 0.03 148 148
Overall 0.2 -0.09 .4 0.17 218 214
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours CCT
Meta Analysis
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2.3.7 Meta-Analysis of Visuospatial Outcomes    
Efficacy. Figure 2.12 shows the k = 8 studies comparing pretest–posttest gains 
between CCT and control groups on all visuospatial measures (N CCT = 267, mean 
sample size = 33.37, N controls = 260, mean sample size = 32.5). Four studies 
reported two or more visuospatial outcomes, which were combined into one effect 
size per study. The combined effect size was small and significant (SMD = 0.31, 95% 
CI [0.07, 0.54], p=0.01). The heterogeneity between studies was statistically 
insignificant, I2 = 40.29%, p=0.11. The funnel plot showed a trend towards asymmetry 
towards the right of the mean (Egger’s intercept = 2.54, 95% CI [-0.82, 5.89], 
p=0.06).  
 
Figure 2.12: Forest plot for effects on visuospatial performance (all studies), rank ordered by 
SMD  
 
Moderating effect of CCT types on visuospatial outcomes. Only results from the 
two video game training studies 47,71 were statistically significant (SMD = 0.48, 95% 
CI [0.03, 0.93], p=0.03, I2=0%, p=0.83). Insignificant results were found from 
multidomain CCT (k=3, SMD = 0.42, 95% CI [-0.15, 0.99], p=0.15, I2=69.04%, 
p=0.04) and SOP training (k=3, SMD = 0.14, 95% CI [-0.15, 0.44], p=0.33, 
I2=26.89%, p=0.25). Between-subgroup heterogeneity was not found (Q(2)=1.80, 
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Edwards et al (2002)Combined -0.08 -0.50 0.33 0.69
Miller et al (2013) Rey Figure (Copy) -0.05 -0.51 0.41 0.83
Vance et al (2007) Combined 0.18 -0.13 0.49 0.26
Stern et al (2011) Block Design (WAIS-III) 0.43 -0.19 1.06 0.18
Basak et al (2008) Combined 0.53 -0.11 1.17 0.10
Maillot et al (2012) Combined 0.54 -0.17 1.25 0.14
Lee et al (2012) Motor-free Visual Perception Test 0.60 -0.13 1.33 0.11
Shatil (2013) Hand-eye Coordination 0.83 0.31 1.35 0.00
0.31 0.07 0.54 0.01
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours CCT
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p=0.40), and the rest of the moderator analyses were attempted using all studies 
reporting visuospatial outcomes. 
Practice moderators of CCT efficacy on visuospatial measures: delivery, dose, 
session length and frequency. A subgroup analysis of delivery was not performed as 
only one study61 used home-based CCT. A subgroup analysis of training dose found 
significant between-group heterogeneity (Q(1)=7.14, p<0.01, see Figure 2.13), 
whereby a large effect size was found for total dose of 21-40 hours (k=4, SMD = 
0.61, 95% CI [0.31, 0.92], p<0.01, I2=0%, p=0.78) and insignificant effects for 
smaller doses (k=4, SMD = 0.10, 95% CI [-0.12, 0.32], p=0.39, I2=7.53%, p=0.36). 
Furthermore, meta- regression found a significant positive relationship between 
training dose and visuospatial SMDs (b=0.02, Q(1)=5.83, p=0.02, see Figure 2.14)  
 
Figure 2.13: Forest plot for CCT effects on visuospatial measures by training dose   
 
Design Study name
SMD Lower limit Upper limit p-Value
20 or less Edwards et al (2002) -0.08 -0.50 0.33 0.69
Miller et al (2013) -0.05 -0.51 0.41 0.83
Vance et al (2007) 0.18 -0.13 0.49 0.26
Lee et al (2012) 0.60 -0.13 1.33 0.11
All studies with <20 hours 0.10 -0.12 0.32 0.39
21-40 Stern et al (2011) 0.43 -0.19 1.06 0.18
Basak et al (2008) 0.53 -0.11 1.17 0.10
Maillot et al (2012) 0.54 -0.17 1.25 0.14
Shatil (2013) 0.83 0.31 1.35 0.00
All studies with 20-40 hours 0.61 0.31 0.92 0.00
Overall 0.27 0.09 0.45 0.00
Statistics for each study Std$diff$in$means$and$95%$CIGroup by
Total dose (CAT)
Study name Outcome Statistics for each stu Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
20 or less Edwards et al (2002)Combined -0.08 - .50 0.33 0.69
20 or less Miller et al (2013) Rey Figure (Copy) -0.05 -0.51 0.41 0.83
20 or less Vance et al (2007) Combined 0.18 -0.13 0.49 0.26
20 or less Lee et al (2012) Motor-free Visual Perception Test 0.60 -0.13 1.33 0.11
20 or less 0.10 -0.12 0.32 0.39
21-40 Stern et al (2011) Block Design (WAIS-III) 0.43 -0.19 1.06 0.18
21-40 Basak et al (2008) Combined 0.53 -0.11 1.17 0.10
21-40 Maillot et al (2012) Combined 0.54 -0.17 1.25 0.14
21-40 Shatil (2013) Hand-eye Coordination 0.83 0.31 1.35 0.00
21-40 0.61 0.31 0.92 0.00
Overall 0.27 0.09 0.45 0.00
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours CCT
Meta Analysis
      71
 
Figure 2.14: Meta-regression of CCT dose (total training hours) on visuospatial SMDs. 
 
Only a session duration of 30-60 minutes was effective on visuospatial measures 
(k=5, SMD = 0.33, 95% CI [0.01, 0.64], p=0.04, I2=52.44%, p=0.08). Shorter sessions 
were ineffective (k=2, SMD = 0.21, 95% CI [-0.42, 0.84], p=0.51, I2=55.57%, 
p=0.14), but there was no between-subgroup heterogeneity (Q(1)=0.10, p=0.75).  
Moderator analysis of session frequency was not performed as there was only one 
study with more than 3 weekly sessions61 and only one study with a single session per 
week69. A series of meta-regressions did not find any significant relationship between 
visuospatial SMDs and session duration or frequency (data not reported).  
Study design moderators of CCT efficacy on visuospatial measures: control 
condition, blinding and type of outcomes. Results from active-controlled trials were 
positive (k=3, SMD = 0.48, 95% CI [0.04, 0.93], p=0.03, I2=58.45%, p=0.09), 
whereas no-contact control studies did not show significant effect (k=5, SMD = 0.18, 
95% CI [-0.1, 0.46], p=0.20, I2=24.13%, p=0.26), but no between-subgroup 
heterogeneity was noted (Q(1)=1.25, p=0.26).  
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Figure 2.15 presents a subgroup analysis of computerised testing.  There was a 
significant between-group heterogeneity (Q(1)=4.98, p=0.03) between significant 
outcomes for computerised testing (k=4, SMD = 0.48, 95% CI [0.20, 0.75], p<0.01, 
I2=17.41%, p=0.30) versus null results for paper-based visuospatial measures (k=5, 
SMD = 0.09, 95% CI [-0.10, 0.29], p=0.35, I2=0%, p=0.44). A subgroup analysis of 
blinding condition was not performed as all studies were unblinded. 
 
Figure 2.15: Forest plot for CCT effects on language by test administration  
 
Study quality moderators of all-type CCT efficacy on visuospatial measures. A 
meta-regression analysis did not find any relationship between visuospatial SMDs and 
PEDro scores (b<0.01, Q(1)<0.01, p=0.99).  
2.3.8 Meta-Analysis of Executive Function Outcomes    
Efficacy. Figure 2.16 shows the k = 24 studies comparing pretest–posttest gains 
between CCT and control groups on the broad domain of executive functions (N CCT 
= 1,415, mean sample size = 58.36, N controls = 1,345, mean sample size = 56.04). 19 
studies reported two or more executive functions outcomes, which were combined 
into one effect size per study. The combined effect size was statistically insignificant 
(SMD = -0.01, 95% CI [-0.09, 0.06], p=0.72). Furthermore, heterogeneity between 
Test Study name Statistics for each study
SMD Lower limit Upper limit p-Value
Paper-based Edwards et al (2002) -0.08 -0.50 0.33 0.69
Miller et al (2013) -0.05 -0.51 0.41 0.83
Vance et al (2007) 0.09 -0.22 0.41 0.55
Stern et al (2011) 0.43 -0.19 1.06 0.18
Maillot et al (2012) 0.54 -0.17 1.25 0.14
All paper-based outcomes 0.10 -0.12 0.32 0.39
Computerised Vance et al. (2007) 0.26 -0.05 0.58 0.10
Basak et al (2008) 0.53 -0.11 1.17 0.10
Lee et al (2012) 0.60 -0.13 1.33 0.11
Shatil (2013) 0.83 0.31 1.35 0.00
All computerised outcomes 0.48 0.20 0.75 0.00
Overall 0.23 0.07 0.39 0.01
Std$diff$in$means$and$95%$CIGroup by
Computerised tests
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
No Edwards et al (2002)Combined -0.08 -0.50 0.33 0.69
No Miller et al (2013) Rey Figure (Copy) -0.05 -0.51 0.41 0.83
No Vance et al (2007) Rey Figure (Copy /36) 0.09 -0.22 0.41 0.55
No Stern et al (2011) Block Design (WAIS-III) 0.43 -0.19 1.06 0.18
No Maillot et al (2012) Combined 0.54 -0.17 1.25 0.14
No 0.09 -0.10 0.29 0.35
Yes Vance et al. (2007) Starry Night (d') 0.26 -0.05 0.58 0.10
Yes Basak et al (2008) Combined 0.53 -0.11 1.17 0.10
Yes Lee et al (2012) Motor-free Visual Perception Test 0.60 -0.13 1.33 0.11
Yes Shatil (2013) Hand-eye Coordination 0.83 0.31 1.35 0.00
Yes 0.48 0.20 0.75 0.00
Overall 0.23 0.07 0.39 0.01
-2.00 -1.00 0.00 1.00 2.00
Favours Control Favours CCT
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studies was null, I2 = 0%, p=0.66. The funnel plot did not reveal asymmetry (Egger’s 
intercept = 0.17, 95% CI [-0.49, 0.83], p=0.30).  
A post—hoc analyses of executive functions subdomains showed a trend towards 
significance in the unfavourable direction for the Trail Making Test A and B 
outcomes, with small, negative and homogenous effect (k=9, SMD = -0.20, 95% CI [-
0.41, 0.005], p=0.06, I2=32.82%, p=0.16). None of the outcomes for other executive 
subdomains (inhibition, planning, reasoning, shifting and task-switching) neared 
statistical significance, and no further subgroup analyses were conducted.  
 
Figure 2.16: Forest plot for effects on executive functions (all studies), rank ordered by SMD  
  
Study name Outcome Statistics for each study Std diff in means and 95% CI
Std diff Lower Upper 
in means limit limit p-Value
Richmond et al (2011) RSPM -0.43 -1.06 0.19 0.18
Ackerman et al (2010) Combined -0.43 -0.88 0.02 0.06
Simpson et al (2012) Combined -0.25 -0.99 0.48 0.50
von Bastian et al (2013)Combined -0.22 -0.74 0.30 0.41
Brehmer et al (2012) Combined -0.19 -0.79 0.40 0.52
Barnes et al (2013) Combined -0.18 -0.68 0.31 0.47
Brehmer et al (2011) Combined -0.13 -0.95 0.69 0.75
Shatil (2013) Combined -0.11 -0.61 0.39 0.67
Edwards et al (2002) Combined -0.07 -0.49 0.34 0.72
Edwards et al (2005) Combined -0.07 -0.42 0.28 0.69
Bozoki et al (2013) Card Prediction -0.06 -0.56 0.45 0.83
Dahlin et al (2008) RAPM -0.05 -0.79 0.68 0.89
Vance et al (2007) Trail Making Test B (s) -0.04 -0.35 0.27 0.79
Legault et al (2011) Combined -0.03 -0.72 0.67 0.94
Ball et al (2002) Combined -0.02 -0.12 0.09 0.71
Boot et al (2013) Combined 0.00 -0.62 0.63 0.99
Stern et al (2011) Combined 0.13 -0.50 0.75 0.69
Peretz et al (2011) Combined 0.17 -0.19 0.52 0.36
Nouchi et al (2012) Combined 0.20 -0.59 1.00 0.62
Lampit et al (2013) Combined 0.26 -0.19 0.72 0.25
Basak et al (2008) Combined 0.39 -0.27 1.04 0.25
van Muijden et al (2012)Combined 0.42 -0.12 0.95 0.13
Goldstein et al (1997) Stroop 0.43 -0.42 1.28 0.32
Maillot et al (2012) Combined 0.81 0.05 1.58 0.04
-0.01 -0.09 0.06 0.72
-1.00 -0.50 0.00 0.50 1.00
Favours Control Favours CCT
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2.4 Discussion  
2.4.1 Summary  
Table 2.3 summarises these results, charting visually the evidence for CCT efficacy 
and moderators of efficacy across the seven cognitive domains.  
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All studies 0.27** 0.28** 0.26** 0.41** 0.26* 0.47* 0.31* -0.01 
CCT type Multidomain 0.28* 0.43* 0.26** 0.35 0.33 0.26 0.42 0.05 
 
SOP 0.27** 0.004 0.87 0.48** -0.01 
 
0.14 -0.03 
 
Video games 0.30* 0.23 0.08 0.44* 0.08 0.18 0.48* 0.29 
 
WM 0.26 0.17 0.17 0.37 0.44 
 
  -0.19 
Delivery Centre-based 0.30** 0.22* 0.28 0.46** 0.27 0.59 0.37** 0 
 
Home-based 0.23 0.36 0.24** 0.4 0.27 0.19 -0.05 -0.06 
Dose <20 hours 0.23** 0.1 0.35* 0.40** 0.19 0.74 0.10 -0.05 
 
21-40 hours 0.34* 0.57* 0.16 0.48 0.40** 0.26 0.61** 0.16 
Session 
Length 
<30 min 0.11 0.14 0.21 -0.11 0.27 0.18 0.21 -0.001 
31-60 min 0.33** 0.34* 0.31 0.50** 0.33 0.52 0.38* -0.04 
Frequency 1/wk 0.39* 0.44 0.21 0.51* -0.01 
 
0.18 -0.04 
 
2-3/wk 0.16** 0.15 0.34 0.47** 0.26 0.52 0.43* 0.0008 
 
>3/wk 0.22 0.44 0.17 0.43 0.39 0.18 -0.05 -0.10 
Control Active 0.28* 0.37* 0.34** 0.42* 0.29* 0.29 0.48* -0.05 
 
No-contact 0.21* 0.13 -0.05 0.37** -0.06 0.6 0.18 0.01 
Design Double-blind 0.24** 0.14 0.29** 0.35** 0.36 0.05   0.03 
Assessor-blind 0.86 0.99 0.25 2.26       -0.02 
 
Subject-blind 0.19 -0.02 0.13 0.15 0.29     0.17 
 
Unblinded 0.22* 0.23* 0.27 0.25 0.21 0.64* 0.31* -0.05 
Tests Computerised 0.32** 0.37** 0.25 0.33* .0.27* 
 
0.48** 0.07 
 
Paper 0.24** 0.21 0.29* 0.40* 0.29 0.42 0.09 -0.06 
Table 2.3: Overview of efficacy and moderators of efficacy for CCT in older adults. Coloured 
cells indicate significant outcomes from a meta-analysis: Yellow = SMD 0-0.4; Orange = SMD 0.4-
0.6; Red = SMD ≥0.6.  White depicts non-significant results with SMDs and grey shows where 
insufficient studies were available for analysis. * p < 0.05. ** p < 0.01. Red borders mark moderators of 
ineffectiveness.  
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To date this is the most comprehensive systematic review of the CCT in the field of 
healthy aging. Maximally, it combines data from 37 trials and 4310 subjects. For the 
first time, the objective of this meta-analysis was not simply a description of 
aggregate efficacy but also an understanding of what moderators may be impacting on 
efficacy variance. 
Taken together, this review suggests CCT is effective: significant low-to-moderate 
effect sizes were observed for memory, WM, processing speed, attention and 
visuospatial outcomes when specifically compared to active control conditions. 
Efficacy on language was weak and mainly present in studies of low quality. Notably, 
no efficacy on executive function was observed in any analysis.  
Some alternative explanations for the observed effect sizes can be ruled out. 
Publication bias was uncommon and thus an unlikely explanation for efficacy. Also, 
70% of the studies were active-controlled and so this is not a major limitation in the 
literature. However, it is possible that at least some of the active-controlled study did 
not adequately control for expectation bias42, given only 8 of the 26 active-controlled 
studies (31%) were double-blinded, introducing possible bias. Overall, study quality 
was moderate (average PEDro score = 6.49), and so further work to improve the 
quality of evidence is required.  
For the first time, this meta-analysis found evidence for efficacy moderators, 
revealing several CCT factors that meet the stringent Q-test criteria for between-
subgroup heterogeneity, along with other “trend” moderating factors that distinguish 
between effective and non-effective training (but did not meet Q-test threshold). 
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Significant moderating effects were found for type of CCT on memory favouring 
multidomain training; control type in WM favouring active-controlled studies; 
blinding and study quality of language outcomes favouring unblinded studies and a 
negative relationship between study quality and results; and total training dose on 
visuospatial skills favouring a total dose of 21-40 hours. Other possible moderators 
that did not meet the Q-test threshold are given in Table 2.2, but should be considered 
as practice factors when designing future studies rather than as definite evidence of 
moderating effect33.  Each of these potential moderating factors are next discussed in 
more detail. 
2.4.2 The Anatomy of CCT  
Along with interventions aimed at reducing cardiovascular risk factors, cognitive 
interventions including CCT have been frequently studied as possible primary and 
secondary ARCD prevention strategies. These studies require large sample sizes and 
take years to complete, but lack of knowledge about how to optimisize the 
interventions or measure outcomes reduce their feasibility. For example, two large 
trials involving CT (along with other interventions) are currently underway72,73, each 
involving a sample size of 1,200 participants for a period of five years. Despite both 
being members of a major European collaboration, these two trials use markedly 
different cognitive interventions. The Multidomain Alzheimer Preventive Trial 
(MAPT73) provides 12 120-minute strategy training sessions, starting with 8 sessions 
of reasoning training and followed by 4 sessions of mnemonic training. Conversely, 
the training protocol of the Finnish Geriatric Intervention Study to Prevent Cognitive 
Impairment and Disability (FINGER72) begins with 10 group 60-90 minute sessions, 
after which participants train on a WM CCT program for 10-15 minutes three times 
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per week for six months at home. As discussed below it is clear that these design 
choices are not supported by the findings of this review.  
Since the effects of CCT tend to be limited to the trained domains45, multidomain 
programs are more likely to tap the cognitive complexity of everyday tasks and global 
measures of cognition. Indeed, as can be seen in Table 2, only multidomain training 
was found effective on memory (SMD=0.43) and WM (SMD=0.26). It should be 
emphasised that of the 20 studies reporting outcomes from multidomain CCT, 19 
trained all targeted domains throughout the whole training period, and only one46 
trained a set of domains for half of the time and a different set for the remaining 
period, reporting negative outcomes. Furthermore, this review found WM training as 
particularly ineffective on transfer tasks, consistent with a recent meta-analysis of 
WM in younger cohorts74. Similarly, neither SOP training nor video games were 
effective beyond the trained domains. A balanced multidomain program is therefore 
key moderator of CCT effectiveness when aiming for positive memory outcomes.  
Supervised administration might also prove another important component in the 
effectiveness of CCT, as centre-based, therapist-guided CCT programs were effective 
on memory (SMD=0.22), processing speed (SMD=0.46) and visuospatial skills 
(SMD=0.37), whereas home-based training was effective only on WM (SMD=0.24). 
Trainers may help ensure adherence, increase motivation, support trainees’ work on 
challenging tasks and provide nonspecific effects such as social interaction and 
activities, involving organising travel to the training centre times, considered 
important elements in cognitive remediation therapy75. Furthermore, as the training 
program progresses, tasks may become more challenging and technical problem may 
arise, bringing about frustration on behalf of trainees that could be largely prevented 
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when guidance and support are available. For example, in their active-controlled trial 
of home-based CCT, Smith et al25 reported 19 dropouts due to frustration, of which 16 
dropped out from the CCT group. Indeed, group administration of non-computerised 
memory training was found as more effective than individual training in several 
trials76-78 and in a meta-analysis of mnemonic training in older adults79, whereas 
several trials of different reasoning strategy training did not find difference between 
the two training conditions80,81.  Conversely, whilst the only trial to date comparing 
centre-based to home-based administration did not find differences between the two 
forms of administration32, it should be noted that the trial included only ten hours of 
training on one exercise, and the outcome measure was very similar to the trained task 
(SOP training). Determining the added value of centre-based training is therefore a 
critical point for further research, as this type of administration is likely to be more 
expensive than training at-home8, and may therefore only be justified from a health 
economic view if supervised administration produces a major difference in CCT 
outcomes.  
Finally, Table 2.3 suggests two important findings concerning the temporal dynamics 
of CCT. First, short sessions (<30 minutes) are probably not challenging enough to 
induce cognitive benefits. Along with home-based administration, this finding may 
partially explain the negative results of Owen et al’s82 large trial of CCT in young and 
middle-aged adults (besides several other design flaws with this study83). It is possible 
that short sessions are insufficient to induce synaptic plasticity, more likely to occur 
after 30-60 minute of stimulation84. Second, here it was found that training programs 
that consist of more than 3 sessions per week are clearly ineffective. This is in line 
with prior work suggesting that 4-7 sessions per week is considerably less effective 
than more dispersed training schedules85,86. It is possible that there is a maximal 
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threshold intensity for cognitive training (possibly three hours per week), after which 
factors such as exhaustion may interfere with training gains.  
2.4.3 Recommendations for Future CCT Trials 
As opposed to all other domains, this review did not find any effect of CCT on 
executive functions. In fact, significant results on executive functions were found for 
only one trial, which provided 24 1-hour sessions of a centre-based multidomain 
program using Nintendo Wii exergames versus wait-list control22. As physical 
exercise has clear effects on executive functions87, it is possible that CCT programs 
could incorporate cognitively challenging exergames to tap this otherwise 
unresponsive cognitive domain. However, because exergames involve costly 
equipment and may not be well suited to the physical capabilities of many older 
adults, new training exercises will need to be developed and trialled. On the other 
hand, it should be also noted that complementing CCT with physical exercise did not 
increase the effect on executive function in two of the trials included in this 
review46,65, and so much further work in this area is required.  
Language skills are another domain for further research and development. This 
review found only six studies that reported language outcomes, and whilst the overall 
result of the meta analysis is positive (SMD=0.47, p=0.04, see Figure 2.9), significant 
results were obtained only when studies were unblinded (see Figure 2.10), and poor 
study quality correlated with language outcomes (see Figure 2.11). More high quality 
studies are required to establish that CCT programs can enhance language skills in the 
elderly.   
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Most trials included in this review, especially those conducted in the past 10 years, 
compared the efficacy of CCT to an active control condition. The results of the meta 
analysis show that CCT effects were greater in active-controlled trials than in trials 
with wait-list or otherwise passive control groups. Active control conditions are vital 
in order to control for a range of nonspecific factors9 and expectancy bias42, and must 
be included in future clinical trials, particularly in light of the fact that that major 
clinical trials such as ACTIVE45, MAPT73 and FINGER72 did not include active 
control arms and hence their outcomes are difficult to interpret.  
2.4.4 Limitations of the Current Meta-analysis  
Despite limiting its scope to studies involving tightly-defined CCT and randomised 
control designs, this review is based on a heterogeneous set of studies with different 
intervention design and hundreds of outcome measures. As a result, many of the 
observed effects were accompanied by significant between-study heterogeneity, 
which in turn makes it more challenging to reveal between-subgroup variability in 
moderator analyses. Also, study outcomes were weighted according to variance 
regardless of the quality of evidence, which may have brought about, in some cases, 
an overestimation of effects (especially for the language domain). Thus, findings from 
this review should be regarded as a guide on the likely conditions for CCT efficacy 
and inefficacy, rather than a final judgement on a particular training strategy or 
program.  
This review was also designed to focus on immediate training gains on 
neuropsychological measures. It therefore provides no indication about the durability 
of the observed gains, nor the transfer from the latter into real-life outcomes such as 
everyday memory, mobility, daily function or risk of long term cognitive morbidity. 
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Similarly, it did not discriminate between possible psychometric differences between 
outcome measures within a specific domain, such as internal and external validity, 
reliability and their neuropsychological rationale. Indeed, the CMA software 
combines test outcomes from a similar domain blindly, irrespective of the relative 
neuropsychological merits of the outcomes. This limitation therefore requires a 
critical interpretation of the findings, as well as to more specific analyses of the data.   
2.4.5 Conclusions  
In healthy older adults, CCT can produce gains in memory, WM, processing speed, 
attention and visuospatial skills. There is no substantive evidence for efficacy on 
language or executive functions. Further research may be required to develop and 
validate CCT exercises that can tap these two domains. Reducing some of the 
methodological heterogeneity between studies by adopting some new standardised 
CCT design features will help mature the field. Use of centre-based multidomain 
programs, standard active control designs, keeping session frequency to less than 
three times per week and more than 30 minutes per session are suggested based on the 
moderator effects found here.  
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Chapter 3: A Dose-Response Relationship between Computerised 
Cognitive Training and Global Cognition in Older Adults  
3.1 Introduction  
Maintaining cognitive performance in late life is an important priority as nations try to meet 
the challenges posed by population aging1.  Advanced age is typically accompanied by a 
decline in global cognition (GC)2-4, however, individual trajectories exhibit great 
variability5,6 and there is rising interest in non-pharmacological cognitive-based interventions 
to arrest and even reverse these trends7-11. GC summarizes performance across multiple 
cognitive domains such as memory, processing speed, language, executive function and 
attention by averaging scores in each domain into a single composite score12,13. Among older 
individuals, GC composites are predictors of key outcomes such as everyday functioning14,15, 
job performance16, mobility17,18, falls19, and incidence of dementia12. Indeed, dementia is 
itself defined, “by progressive acquired global impairments of cognitive skills and ability to 
function independently”20. For these reasons, composite scores of GC have been advanced as 
an endpoint for prevention-orientated randomized controlled trials (RCTs) in elderly at-risk 
for dementia21-24.  
Computer-assisted cognitive training (CCT) is a prescriptive and efficient way of delivering 
cognitively challenging exercises using game-like stimuli for the purpose of cognitive 
enhancement25,26. Whilst not uniformly effective27-29, reviews of CCT trials in the elderly 
report positive domain-specific cognitive outcomes7,9,25 (see Chapter 2), in line with 
literature linking a more active cognitive lifestyle with reduced dementia risk30-33 and 
compression of cognitive morbidity34. But clinical implementation of CCT in this age group 
is limited by three major knowledge gaps8,9. First, there is no high quality evidence 
supporting the efficacy of any CCT regimen on far-transfer outcomes such as GC, general 
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everyday functioning, or dementia incidence in those without cognitive impairment10,11,23,27,35 
(see Chapter 2).  In this respect, design of the CCT program is likely to be influential. 
Unidomain training does not tend to transfer beyond tasks that share similar cognitive 
demands as the training itself36-38. In fact Chapter 2 showed that multidomain training may 
be more appropriate when targeting general cognitive performance. Second, as identified in 
Chapter 2, inadequate double-blinding is another methodological issue for cognitive 
interventions that are particularly susceptible to Hawthorne effects39. Third, and perhaps 
most importantly, dose-response relationships between CCT and GC are yet to be 
established, nor a detailed understanding of the decay rate for any putative therapeutic 
effects, essential information for clinical implementation9 and technological innovation.  
The objective of the Timecourse Trial was to examine the net effect of CCT on GC and its 
four component cognitive domains in older adults with a range of dementia risk factors, as 
well as chart the evolution of clinical benefits during and 12-months after the cessation of 
training. We hypothesised that: 1)CCT will induce improvement in GC over and above 
active control training; 2)Training effects will increase gradually over the training period and 
wane gradually after training cessation; and 3)Training effects will be still significant three 
months after training cessation.  To test these hypotheses, we randomly assigned 80 older 
adults to 36 sessions of either supervised, centre-based, multi-domain CCT or fully matched 
active control memory and attention-based training.  
3.2 Methods   
Inclusion and exclusion criteria.  Inclusion criteria were 65 years of age or older, English 
fluency, ability to attend 3 sessions per week at the training centre and sufficient physical 
ability to use a computer. Exclusion criteria were a history, diagnosis or treatment for 
dementia, diagnosis or treatment for depression in last 6 months, stroke in last 12 months, 
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major neurological and/or psychiatric disorder requiring current treatment, lack of personal 
informant, already undertaking a CCT program or current alcohol abuse. Further exclusion 
criteria included Mini Mental State Examination (MMSE) ≤23, Informant Questionnaire on 
Cognitive Decline in the Elderly (IQCODE) > 3.3, or Geriatric Depression Scale (15-item 
GDS) ≥8. This study was approved by the Human Research Ethics Committee at the 
University of New South Wales, Sydney. All participants provided written informed consent 
prior to randomization. All procedures took place in a training centre in Sydney, Australia. 
Dementia risk factors. For each participant we computed a dementia risk factor sum 
(DRFS) based on a single point for any of the following: age ≥ 85 years, education ≤10years, 
any cardiovascular risk factor (current or past smoker, hypercholesterolemia, hypertension, 
ischemic heart disease, atrial fibrillation or diabetes), physical inactivity by CHAMPS 
estimated caloric all cause activity <184340, family history of dementia, subjective memory 
complaint based on GPCOG questions41, or baseline memory domain score below 1.5SD of 
age-matched norms. The maximum theoretical DRFS is therefore 12. Figure 3.1A shows the 
frequency for each possible DFRS score. Fig 3.1B shows the frequency for individual risk 
factors within the whole sample. The average DFRS in our sample was 3.3 (±SEM 0.19), 
ranging from 1 – 9. All subjects therefore carried at least one recognized dementia risk factor 
and 47% had 3-4 risk factors.    
Randomization and blinding. Participants were randomized using a computer-generated 
randomization in a 1:1 ratio. Assessors were blinded to group allocation and participants 
were not aware of the study hypotheses. Allocation was concealed until the first day of 
training and on-going participant blinding achieved by describing CCT as a “diversified set 
of cognitive exercises”, and AC as “comprehension and memory exercises.” Both 
interventions were administered in a supervised group format of one trainer to ten 
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participants (maximum) during three 30-45 minute sessions per week for a total of 36 
sessions over 12-weeks, in a designated training room. A member of the study team 
supervised all training sessions.    
!
Figure'3.1:'Frequency'of'cumulative'(A)'and'specific'(B)'dementia'risk'factors'across'the'whole'ITT'sample'
(N'='77).''!
Computerized Cognitive Training (CCT). We designed and administered a CCT program 
based on 24 exercises from the COGPACK package, Version 8.1 (Marker Software) to cover 
the five cognitive domains: memory, attention, response speed, executive functions and 
language. Each exercise contained 4-8 levels of increasing difficulty. The exercises were 
administered according to a predefined order that ensured equal (≈20%) allocation of 
training time on each cognitive domain. The complete COGPACK training regimen is 
described in the Appendix 1. A brief description of each exercise is provided in Appendix 
2.     
Active Control (AC). This intervention was developed for a previous RCT to control for 
general sensory-motor stimulation, computer use, socialization, motivation, simple learning 
A! B!!! B!
A!
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and memory demands, and other non-specific effects inherent to supervised CCT42. 
Participants viewed seven National Geographic videos per session on computer and 
answered multiple-choice questions immediately after each presentation. An electronic 
library of the 390 videos and associated multiple choice questions are available from the 
corresponding author. 
Outcome measures. The primary outcome was change across four cognitive domain 
composites (memory, information processing speed, executive functions and global 
cognition) over six timepoints: baseline and after 9 and 36 training sessions (FU1 and 2, 
respectively), as well as 3, 12 and 52 weeks after training cessation (FU3, 4 and 5 
respectively).  
Memory and information processing speed z-score composites were obtained from the 
Mindstreams battery43. Executive function z-score composite was defined as the average of 
Mindstreams Stroop Interference test and CANTAB Stockings of Cambridge problems 
solved in minimum moves score. Global Cognition Score was obtained by averaging these 
three z-domain scores. Mindstreams tests have three alternate forms that provide good test-
retest reliability, are sensitive to differences between healthy elderly and those with mild 
cognitive impairment, and have been used widely in RCTs44. The CANTAB Stockings of 
Cambridge test is a validated measure of planning and spatial problem solving45.  
In addition, at three of the five FU assessments we evaluated the language domain by 
averaging performance in the Controlled Oral Word Association Test (COWAT)46, and short 
forms of the Boston Naming Test47 (baseline and FUs 2, 4 and 5). In-house computerized 
versions of the Recognition Memory Test48 and WAIS-IV Matrix Reasoning were also 
administered at these timepoints (baseline and FUs 2, 4 and 5). These four tests were 
included in the more expansive post hoc Global Cognitive Score. Finally, to assess potential 
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effects of CCT on everyday performance, we administered the Bayer Activities of Daily 
Living Scale49 at baseline and follow-up 5.   
Statistical analysis. In order to assess the efficacy of CCT over the six timepoints, we 
conducted linear mixed-modeling repeated-measures (MMRM) analyses using SPSS version 
21 (IBM Statistics). Our model included main effects for Group and Time and a Group X 
Time interaction term. Each cognitive domain score was tested separately. MMRM 
incorporates a model for missing data values and so avoids discrete imputation or omission 
of cases50. All analyses are therefore intention-to-treat (ITT).  
Within-group effect sizes (Cohen's d) were calculated by subtracting mean baseline scores 
from mean score at each time point divided by standard deviation at baseline. Bias-corrected 
net effect size (NES) were estimated by subtracting Cohen’s d of the AC group from that of 
the CCT group, and then applying a bias correction factor 1-(3÷4[(nCCT – nAC – 2) – 1])51. 
Absolute differences between CCT and AC for outcomes at each follow-up time point were 
also calculated along with the associated 95% confidence interval. 
 
3.3 Results  
Participants, Attrition & Protocol Adherence                   
A total of 80 older participants were enrolled into this prospectively registered RCT 
(ACTRN12611000702910). Of these, 77 participants (39 in the CCT group and 38 in the AC 
group) completed baseline assessment and are included in all intention-to-treat (ITT) 
analyses. Twelve participants (15.6%) withdrew during the intervention period (8 in the CCT 
group, 4 in the AC group, 2-sided χ2 p = .347), and 10 additional participants (13%, five in 
each group) were lost to longitudinal follow-up (see Figure 3.2). No baseline 
sociodemographic or clinical differences were noted between dropouts and those who 
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completed intervention. There were also no systematic differences in protocol adherence in 
the CCT group (35.1 sessions, 97.5%) compared to AC training (34.7 sessions, 96.4%, p-
value = 0.581).  
!
Figure'3.1:'Study'design'and'participant'flow' 
 
At baseline, the age range of participants was 65 to 90 years (mean age 72.1, SD = 6.2), 
68.8% were female, MMSE scores ranged from 24 to 30 (mean MMSE 28, SD = 1.6), 28.5% 
 97 
had 10 or fewer years of education, and the average NART-r IQ was 112.5 (SD = 11). All 
subjects had at least one established dementia risk factor, the most prevalent being subjective 
memory complaints (68.9% in women; 70.1% men – see Figure 3.1 for further details). 
There were no significant demographic or cognitive differences between the groups at 
baseline (see Table 3.1).      
Strength and durability of effects on Global Cognition   
Linear mixed-modelling repeated-measures ITT analysis revealed an overall significant 
Group X Time interaction on GC favouring CCT across the 15-month trial period (F-
value=3.297, p=0.006). As shown in Figure 3.3, GC improved significantly from baseline in 
the CCT group compared to AC after nine sessions (FU1: Net Effect Size, NES=0.33). The 
effect increased after 27 additional sessions (FU2: NES=0.49). This gain diminished by 
about one-third three weeks after cessation (FU3: NES=0.32), but a significant medium-
sized effect was maintained three months post training (FU4: NES=0.30). A small NES was 
noted one year after training finished (FU4: NES=0.21).    
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Table 3.1. Baseline characteristics. 
 
Demographics CCT (n = 39) AC (n=38) P -value 
  Age (years) 72.2 (7.1) 71.9 (5.3) .815 
  Female Sex, No. (%) 29 (74) 24 (63) .289 
  Native English Speakers, No. (%) 30 (78) 29 (76) .950 
  NART-r (SD) pFSIQ* 112.6 (10.1) 112.3 (11.0) .896 
  Prior computer use 35 (89.7) 36 (94.7) .414 
Dementia risk factors 
  
 
  Subjective memory complaints†, No. (%) 27 (69.2) 27 (71.1) .861 
  Hypertension, No. (%) 12 (30.8) 20 (52.6) .052 
  Hypercholesterolemia, No. (%) 14 (35.9) 14 (36.8) .931 
  Diabetes, No. (%) 1 (2.6) 5 (13.2) .083 
  Ischemic Heart Disease, No. (%) 2 (5.1) 6 (15.8) .125 
  Atrial Fibrillation, No. (%) 3 (7.7) 4 (10.5) .665 
  Physical inactivity‡, No. (%) 10 (25.6) 11 (28.9) .802 
  Low education (≤10 years), No. (%) 11 (28.2) 11 (28.9) .501 
  Family history, No. (%) 8 (20.5) 9 (23.7) .789 
  Past smoking, No. (%) 23 (59.0) 21 (55.3) .742 
  Current smoking, No. (%) 2 (5.1) 0 (0) .157 
  DRFS (SD) 3.0 (1.6) 3.44 (1.6) .221 
Clinical 
  
 
  IQCODE score (SD) 3.05 (0.12) 3.1 (0.13) .111 
  GPCOG examination score (SD) 7.92(1.3) 8.05 (1.0) .631 
  MMSE (SD) 28.2 (1.4) 27.8 (1.8) .267 
  B-ADL (SD) 1.58 (0.52) 1.63 (0.65) .702 
  GDS (15-item) (SD)  1.7 (1.4) 1.3 (1.5) .225 
Quality of life 
  
 
  QOLS (SD) 88.8 (9.8) 89.7 (9.2) .690 
  SF36 physical component (SD) 72.0 (18.0) 74.6 (17.4) .522 
  SF36 mental component (SD) 83.0 (9.9) 82.6 (11.1) .868 
Data are n (%) or mean (SD). DRFS=dementia risk factor score. GDS=geriatric depression scale. IQCODE=informant 
questionnaire on cognitive decline in the elderly. GPCOG=general practitioner assessment of cognition. MMSE=mini 
mental state examination. NART=national adult reading test (revised). B-ADL=Bayer activities of daily living. 
QOLS=quality of life scales. SF36=short form health survey. *IQ-equivalent. † defined as 4 points or less in the GPCOG 
questionnaire(52). ‡ defined as CHAMPS (51) estimated caloric all cause activity score <1843.  
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Figure'3.2:'Net effect sizes (NES) for domain summary scores across the 15-month trial period as measured after 9 
and 36 training sessions (FU1 and 2, respectively), as well as 3, 12 and 52 weeks after stopping training (FU3-5). NES 
calculated as Cohen’s d [(post mean -pre mean) ÷ pooled baseline standard deviation] for CCT minus AC group, and 
then applying a bias correction factor (1-(3÷4[(nCCT – nAC – 2) – 1]) 51.'
 
To further evaluate whether change in language abilities affect the observed efficacy on GC, 
on a post hoc basis we computed a more expansive Global Cognition Score that included two 
language domain tests, as well as additional memory and executive function tests that were 
administered only at follow-ups 2, 4 and 5 because of lack of alternate forms (see Methods 
section). The overall Group X Time interaction remained significant (F-value=9.004, 
p<0.001), and produced stronger effect size estimates at specified timepoints (FU2 NES = 
0.65; FU4 NES=0.47; FU5 NES=0.36).   
Domain-specific effects 
Linear mixed-modeling repeated-measures ITT analyses revealed significant Group X Time 
interactions favouring CCT on two of four composite scores, namely, the memory domain 
(p=0.011) and the processing speed domain (p=0.037), as well as a trend on the language 
domain (p=0.067). There were no significant findings for the executive function domain (see 
Table 3.2).  
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Dose Response and Decay of CCT Therapeutic Effects                               
As opposed to GC, the effect on memory domain (see Figure 3.3 and Figure 3.4) was 
negligible after nine sessions (FU1: NES=0.09), but reached a similar effect to GC after 36 
sessions (FU2: NES=0.49). These gains more than halved three weeks after stopping training 
(FU3: NES=0.26) and continued to diminish one year later (FU4: NES=0.17; FU5: 
NES=0.16). CCT effects on the processing speed domain showed a unique pattern (Figure 
3.3 and Figure 3.4). The therapeutic effect peaked after nine sessions (FU1: NES=0.40), and 
then declined after 36 sessions (FU2: NES=0.21). However, medium-sized effects favouring 
CCT were maintained throughout the three-month post training period (FU3: NES=0.49; 
FU4: NES=0.32), diminishing by approximately a half one-year after training stopped (FU5: 
NES=0.13).   
Longitudinal effect on activities of daily living               
One year after training cessation there was no significant Group X Time interaction 
improvement on Bayer Activities of Daily Living scale, resulting from a small effect size in 
the CCT group (ES 0.20) and no change in the AC group (ES 0.00; NES=0.20, F = 0.162 p= 
0.689).  
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Table 3.2. Cohen’s d effect size for CCT and AC groups (95% confidence interval).  
  CCT  AC Bias 
Corrected 
Net ES 
ITT Mixed Model 
TIME X GROUP 
 
 
d 95% CI  d 95% CI   
 
F-
Value p-value 
Global 
Cognition 
FU1 0.70 (0.24 to 1.16)  0.37 (-0.09 to 0.82) 0.33 
3.297 0.006 
FU2 1.12 (0.61 to 1.62)  0.62 (0.15 to 1.09) 0.49 
FU3 1.19 (0.68 to 1.7)  0.87 (0.39 to 1.36) 0.32 
 FU4 1.34 (0.81 to 1.86)  1.04 (0.54 to 1.53) 0.30 
  FU5 1.27 (0.72 to 1.81)   1.05 (0.54 to 1.57) 0.21 
Memory 
Domain FU1 0.28 
(-0.17 to 
0.73)  0.20 (-0.26 to 0.65) 0.09 
3.028 0.011 
FU2 0.87 (0.38 to 1.36)  0.38 (-0.09 to 0.84) 0.49 
 FU3 0.66 (0.18 to 1.14)  0.40 (-0.07 to 0.87) 0.26 
 FU4 0.68 (0.19 to 1.16)  0.51 (0.04 to 0.98) 0.17 
  FU5 0.84 (0.32 to 1.36)   0.68 (0.18 to 1.18) 0.16 
Information 
Processing 
Speed 
FU1 0.62 (0.16 to 1.09)  0.22 (-0.23 to 0.67) 0.40 
2.403 0.037 
FU2 0.73 (0.23 to 1.22)  0.52 (0.05 to 0.99) 0.21 
FU3 1.01 (0.5 to 1.52)  0.69 (0.21 to 1.16) 0.32 
 FU4 1.19 (0.67 to 1.72)  0.87 (0.39 to 1.35) 0.32 
  FU5 1.00 (0.46 to 1.54)   0.86 (0.36 to 1.37) 0.13 
Executive 
Function 
Domain 
FU1 0.71 (0.24 to 1.17)  0.46 (0 to 0.92) 0.24 
1.036 0.397 
FU2 0.94 (0.44 to 1.44)  0.49 (0.02 to 0.96) 0.45 
FU3 1.02 (0.52 to 1.52)  0.87 (0.38 to 1.35) 0.15 
 FU4 1.18 (0.66 to 1.69)  0.90 (0.41 to 1.4) 0.27 
  FU5 1.01 (0.48 to 1.53)   0.80 (0.3 to 1.3) 0.20 
Language 
Domain  FU2 0.76 (0.28 to 1.25)  0.55 (0.08 to 1.02) 0.21 2.433 0.67 
 FU4 0.71 (0.22 to 1.20)  0.52 (0.08 to 0.99) 0.18 
 FU5 1.01 (0.48 to 1.54)  0.90 (0.38 to 1.41) 0.11 
Extended 
Global 
Cognition  
FU2 1.24 (0.73 to 1.75)  0.59 (0.11 to 1.06) 0.65 
9.004 <0.001 
FU4 1.33 (0.80 to 1.85)  0.86 (0.38 to 1.34) 0.47 
FU5 1.35 (0.80 to 1.89)  0.98 (0.47 to 1.49) 0.36 
Bias-corrected net effect size (NES) is difference between two effects after correction. F-value refers to linear mixed 
model with Time (six repeated measures), Group and Group X Time terms in model. P-value refers to Group X Time 
interaction.    
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Figure'3.4:'Mean change on GC, memory and information processing speed across the six time points. 
CCT=computerized cognitive training. AC=active control. FU1=after 9 training sessions. FU2=after 36 training 
sessions. FU3=3 weeks after cessation. FU4=12 weeks after cessation, FU5=52 weeks after cessation. Graphs depict 
change from baseline in SD units based on ITT MMRM estimated marginal means ±SEM.    !
3.4 Discussion     
To the best of our knowledge this is the first randomized, double-blind, active-controlled 
trial to demonstrate efficacy of computerised cognitive training on GC in non-impaired older 
adults27,52. The magnitude of the net effect size at the end of 36 hours of training is sufficient 
(NES 0.49) to be of clinical interest. Some of these benefits were preserved as far out as 12 
months after completing training, but as expected, decayed relative to combined retest and 
non-specific effects in the active control group. This comparison group was the most 
rigorous implemented thus far, designed to take into account of sensorimotoric, mnemonic, 
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attentional, motivational, social and trainer-related stimulation. In addition, we chose 
outcome measures with multiple available forms that were functionally dissimilar to the CCT 
exercises, and analysed results on cognitive composite scores rather than individual tests, 
further increasing their reliability6. For the first time, we also examined cognitive outcomes 
at multiple time points during and after CCT, providing new insights into dose-response 
relationships. Memory effects for example continue to display a steep upward trajectory even 
after 36 training sessions, but decay rapidly following training offset, in contrast to 
processing speed effects which peak after 9 sessions but then are largely resistant to decay 
for at least 3 months following the end of training.  
Previous trials of non-computerized cognitive interventions have reported improved GC in 
healthy and mildly impaired older adults53-56, however, these employed single-blinded wait-
list control designs and multi-faceted interventions that make interpretation difficult39,57. 
Notably, the NES in these trials were considerably smaller than reported here under more 
rigorous conditions. Interestingly, three recent well-designed RCTs in the elderly have failed 
to detect GC effects following CCT27,58,59. Similar to our study, these used multi-domain 
CCT and a comparable number of training sessions, but unlike our study, CCT was self-
administered at home rather than in a supervised group setting. This raises the possibility that 
expert supervision involving feedback, motivational support and emphasis of applicability of 
training to everyday life may be a key factor moderating CCT outcomes60,61, as clearly 
supported by the moderator analysis in Chapter 2.  
For the first time, we also examined cognitive outcomes at multiple time points during and 
after CCT, providing new insights into dose-response relationships. Memory effects for 
example continue to display a steep upward trajectory even after 36 training sessions, but 
decay rapidly following training offset, in contrast to processing speed effects which peak 
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after 9 sessions but then are largely resistant to decay for at least 3 months following the end 
of training. This information may help develop more effective CCT software in the future. 
Moreover, the fact that CCT has effected memory and processing speed but not language and 
executive function is completely consistent with the results of Chapter 2.    
The issue of which CCT software package is optimal for enhancing GC in this population 
remains open in the absence of head-to-head RCTs. We used COGPACK, which has a 
relatively rich history within the cognitive rehabilitation setting 62 and is convenient for 
research purposes. However, COPGACK relies on now dated technology that lacks useful 
auditory exercises and relies on a trainer rather than an automated algorithm to create the 
training regimen and adapt training content. Accordingly, there is great scope for improving 
beyond these reported outcomes with new software that takes into account underlying dose-
response functions.  
It is also important to note that whilst efficacy on GC may be a necessary condition for 
primary dementia prevention, it is not sufficient. For this purpose, robust and simultaneous 
effects on daily function are required 23. We found only small and non-significant effects 
using the Bayer ADL measure at our 12-month post training assessment (NES=0.2); based 
on these results 80% power would require a total final sample size of 787. This finding is 
therefore in line with the weak IADL effects (NES=0.29) found in the large ACTIVE trial 
following paper-and-pencil reasoning training63. The overarching clinical challenge for CCT 
researchers is therefore to demonstrate far transfer to everyday function, an issue closely 
related to development of validated tools sensitive enough to detect treatment-related 
functional change in asymptomatic and preclinical individuals37. 
For the full anti-brain-aging potential of CCT to be realised evidence needs to move beyond 
simple efficacy to understanding fundamental therapeutic characteristics. We found that 
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supervised, centre-based, multidomain CCT is effective at improving global cognitive 
performance in older individuals over the long term, and moreover, this outcome was based 
on a complex pattern of dose-dependent gains during training and time-dependent decay 
following training offset. This information will be vital to the design of next generation CCT 
technology, as well as for helping clinicians and researchers make the most this intervention. 
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Chapter 4: Timecourse of CCT-induced structural and 
functional brain plasticity: A Pilot Study  
Introduction   
Throughout the past decade neuroimaging studies of CT studies have been influential 
in providing an insight into the human brain’s neuroplasticity, and hence helped 
reform longstanding attitudes about the inevitability of degeneration and decline in 
late life. As the field moves from traditional ‘does brain training work?’ about the 
questions to more detailed investigation about the mechanisms of action1 and 
optimised practice parameters, neuroimaging may have several roles to play2-4:  
First, the main evidence base for the field is centred around neuropsychological 
measures of cognition (see Chapter 2), and so there remains an absence of a solid 
neurobiological theory for clinical effectiveness, something that can only be 
established when several studies are able to show consistent links between cognitive 
change and measures of structural and functional brain adaptation. Second, imaging 
can help determine whether CT reverses or attenuates longitudinal patterns of 
degeneration or age-associated neurobiological dysfunction. Third, neuroimaging 
have help identify ‘brain-training responsive brains’, that is, multivariate 
neuroimaging patterns at baseline that can distinguish between those individuals that 
will have a robust clinical response to training from those who will not. Finally, 
development of new CT exercises could be immensely enhanced by looking at 
neuroplastic processes stimulated by specific exercises, feeding this back into exercise 
development in an iterative cycle. 
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Alas, a number of methodological challenges will need to be solved before 
neuroimaging can fulfil these roles. Magnetic resonance imaging (MRI) and positron 
emission tomography (PET) scans are currently too expensive to become common 
endpoints in clinical trials, and standards of image processing, analysis and reporting 
need to be improved5. Importantly, in vivo imaging is not yet sensitive enough to 
detect changes at the molecular and cellular scale, as well as other likely relevant 
microstructural processes such as neurogenesis and angiogenesis6. The same problem 
exists in regard to quantitate electroencephalography (qEEG), which, despite its 
relative simplicity (notably the ability to record task-dependent cortical activity for a 
long duration without having to lay in a scanner), and low cost, it has yet to be 
established as a reliable and sensitive brain imaging technique6,7.         
Notwithstanding these challenges, at least eight controlled trials have demonstrated 
CT-induced brain plasticity in healthy elderly using MRI8-15 (see also a review by Suo 
and Valenzuela2), and a similar number of studies have done so in subjects with 
MCI3. In addition, at least two well designed studies have used qEEG to study 
specific CCT tasks in healthy elderly16,17, and an array of imaging studies have used 
MRI outcomes to study CT effects in neuropsychiatric populations (reveiwed by 
Vinogradov et al4). 
To date neuroimaging studies of CT have used inconsistent methods and present a 
heterogeneous body of evidence (like the clinical studies reviewed in Chapter 2). To 
the best of our knowledge, no study has yet reported null effects of CT on any 
neuroimaging outcomes, with the literature populated only by positive results, clearly 
ignoring or underreporting statistically insignificant results.  There is therefore strong 
reason to believe that the current literature is biased.  
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As part of the Timecourse Trial (Chapter 3) we therefore designed and conducted a 
pilot investigation to examine the utility of MRI measures of multidomain CCT-
induced neuroplasticity. More specifically, we aimed to 1) pilot test multimodal 
neuroimaging to assess evidence for mediating mechanisms of global cognition gains, 
and 2) compare effect sizes from cognitive measures to those generated from 
neuroimaging in order to assess their potential role as endpoints for CCT trials. All 
procedures and analyses were conducted as predetermined, with an emphasis on using 
the most recent data acquisition, processing and analysis tools and testing for 
relationships with cognitive outcomes.  
Methods  
4.1.1 Study Design and Participants   
This study was conducted using a subsample of participants from the Timecourse 
Trial, using the same recruitment, eligibility criteria, randomisation, interventions and 
assessment methods. After giving their consent to participate in the trial, participants 
in whom MRI was not contraindicated (e.g., no metallic implants) were offered to 
participate in the imaging subsample in addition to the main trial. Neither consent nor 
refusal to participate in the imaging subsample affected inclusion, randomisation, 
intervention or cognitive assessments, and cognitive data from participants in the 
imaging subsample was combined with those of the other participants. Inclusion in 
the subsample was determined after randomisation to the main trial based on a 2:1 
allocation with N = 18, i.e., the first twelve participants from the CCT group and first 
six participants from the AC group who consented to participate in the imaging 
subsample were included in this study.  
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The Timecourse Trial (Chapter 3) was a randomised active-controlled trial of centre-
based multidomain CCT in healthy older adults. After baseline assessment, eligible 
participants received a total dose of 36 one-hour session of either CCT or an active 
control intervention. Additional cognitive assessments were conducted after 9 hours 
(follow-up 1) and 36 hours of training (follow-up 2). Three longitudinal assessments 
were performed 3 weeks, 3 months and 12 months after training cessation. Primary 
outcomes were global cognition, as well as composite scores of memory, information 
processing speed, executive functioning and language.    
4.1.2 Data Acquisition    
Multimodal MRI scans were performed on three occasions, at baseline, after nine 
training sessions (FU1) and after 36 sessions (FU2), using a 3.0-Tesla General 
Electric scanner at the Brain and Mind Research Institute, University Of Sydney. 
Each scan took 45-50 minutes to complete and included:  
1 Structural (sMRI): 3D, T1-weighted whole brain scan (sequence: T1GR; TR/TE 
7.1/2.7ms; slice thickness 1mm without gaps; field of view 256x256; resolution 
1x1mm.   
2 Resting-state fMRI: T2* echo-planar BOLD sequence (T2*EP/RG; TR/TE 
2000/30; slice thickness 4.5mm without gaps; 200 volumes, 6.5 minutes), eyes 
closed. 
3 Proton Magnetic Resonance Spectroscopy (1H-MRS): in left hippocampus 
(20mm M/L, 15mm D/V, 30mm A/P, oriented along the hippocampus) and 
posterior cingulate grey matter (20mm M/L, 20mm D/V, 30mm A/P) using the 
PRESS sequence (TE/TR 20/2000ms, 1024 points, 256 averages). 
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4 Diffusion Tensor Imaging (DTI): 40 directions, TR/TE 10293/55ms, 60 slices, 
2mm3 isotropic.           
 
4.2.3 MRI Preprocessing  
sMRI. Two structural analyses were used. First, we performed VBM longitudinal 
preprocessing pipeline as per our previously published protocol18 using SPM version 
8 (Wellcome Trust Centre for Neuroimaging, London, UK) running on Matlab 2012a 
(MatWorks Inc., Natick, MA). Intra-subject image normalisation was performed for 
the three timepoints (BL, FU1, FU2) combined. Secondly, an analysis of cortical 
structures was performed using the longitudinal pipeline of FreeSurfer19. It creates a 
within-subject template through a variety of steps including image registration, 
normalization, skull-stripping, segmentation of grey and white matter, and delineation 
between the inner grey-white matter and outer pial surface.  The resulting surface 
maps where then used to assess the longitudinal training effect, at both a whole-brain 
(QDEC) and regional level (parcellation), with changes in cortical thickness 
indicative of structural neuroplasticity.    
fMRI. Resting-state fMRI data were preprocessed using the Data Processing 
Assistant for Resting State fMRI toolbox of the SPM8, normalised to standard MNI 
space and smoothed using 8mm kernel. The Resting State fMRI Data Analysis 
Toolkit (REST, www.restfmri.net) was used to generate pre-specified seed-wise 
functional connectivity (FC) maps of the hippocampus and the posterior cingulate. 
Nuisance variables related to white matter, whole-brain and CSF signal and head 
motion were regressed out along with 6 co-registration factors. Individual FC maps 
for each seed and FU were based on voxel-wise correlations between the mean signal 
 115 
of the seed and other regions, and then transformed into z-scores. Baseline FC maps 
for the whole sample are presented in Figures 4.1 and 4.2 below.  
 
Figure 4.1: Baseline whole-brain functional connectivity map for the posterior cingulate seed (t = 
3.93, df = 12, p = 0.001, cluster size threshold =5) on a standardised single T1 template. Hot areas 
represent voxels positively correlated with the seed and cool areas negative correlations. 
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Figure 4.2: Baseline whole-brain functional connectivity map for the right hippocampus seed (t = 
3.93, df = 11, p = 0.001176, cluster size threshold =5) on a standardised single T1 template. Hot 
areas represent voxels positively correlated with the seed and cool areas negative correlations. 
 
1H-MRS. We followed our previously published protocols for MRS processing of the 
five main metabolite signals8,20,21 namely N-acetylaspartate (NAA), Creatine (Cr), 
Cholines (Cho) Myo-inositol (mI) and Glutamate+Glutamine (Glx). Residual water 
signal was first removed by Hankel Lanczos Squares Singular Value Decomposition 
filter. The spectra were then aligned by setting NAA peak to 2.02ppm and baseline 
correction performed (using 150 data points for mean). Finally, we used the 
AMARES jMRUI procedure to quantify the amplitudes of the five metabolite peaks 
and calculated relative amplitudes using Creatine as reference peak. 
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Figure 4.3: Example of ROI placement and baseline spectra – posterior cingulate.  
 
 
Figure 4.4: Example of ROI placement and baseline spectra – left hippocampus. 
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DTI. Fractional anisotropy (FA) data were preprocessed using the Tract-Based 
Spatial Statistics (TBSS) script of the FSL suit, using published methods22. Very 
briefly, TBSS aligns all FA images to a mean FA skeleton, and generates individual 
FA data as a projection onto the mean skeleton.  
4.2.4 Postprocessing and Statistical Analyses  
Voxel-based analyses. A longitudinal general linear model was used to analyse the 
structural VBM-preprocessed and resting state fMRI FC-map data. Both analyses 
were based on a flexible factorial design with three factors (subject, group and time) 
and one interaction (group X time), correcting at the whole-brain cluster-level using a 
false discovery rate (FDR) procedure at the p<0.05 level. Finally, statistically 
significant results were correlated with changes in global cognition (GC) scores in the 
imaging subsample.          
Vertex-based analysis. Vertex-based analysis was conducted on the outputs from the 
FreeSurfer longitudinal pipeline, using the FreeSurfer QDEC toolbox. Three measures 
of cortical thickness change were used to assess for plasticity, namely: 1) annualised 
rate of change (+/-) in mm/year, 2) symmetrised percent change (SPC) with respect to 
the temporal average, and 3) percentage change with respect to baseline (PCL).  A 
longitudinal general linear model was used with group as the main factor. Multiple 
comparisons were corrected using two methods, namely: whole-brain vertex based 
FDR correction, and exploratory small-volume based FDR correction.  
MRS and FA analyses. Preprocessed data was analysed using linear mixed-modeling 
repeated-measures analyses, with Group and Time as main factors and the interaction 
of interest (Group x Time) on SPSS 20. All group x time interactions tested changes 
from baseline to FU1 or change from baseline to FU2.   
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4.3 Results  
Eighteen subjects were initially included in the imaging subsample. Three withdrew 
consent between baseline and FU1 and one passed away between FU1 and FU2. Two 
additional subjects withdraw consent from the imaging subsample but completed the 
main trial, and one subject was excluded from the trial following pathological 
findings in his baseline MRI scan (diagnosed with Parkinson’s disease soon after). A 
total of 12 subjects (CCT: six females, one male; AC: five males, mean age 71.4) 
were therefore analysed on a per-protocol completion basis, using three scans per 
subject.  
VBM whole brain analysis. After FDR correction for multiple comparisons there 
was a significant group x time interaction in the right postcentral gyrus (t=4.6, 
kE=1122, pcorr = 0.003, peak at xyz 39 -25 60) in the CCT group compared to an 
observed shrinkage in that region in the AC group from baseline to both FU1 
(zCCT=0.39; zAC=-0.34) and FU2 (zCCT=0.66; zAC= -0.53). See Figure 4.5 for a 
representation of these results. In addition, there was a significant group x time 
interaction in the right fusiform gyrus (t=4.53, kE=1711, pcorr<0.001, peak at 39 -40 -5, 
see Figure 4.6).  Across the entire sample, there were significant positive correlations 
between changes in the postcentral gyrus and change in global cognition at both FU1 
and FU2 (see Figure 4.5).  
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Figure 4.5: VBM changes in the postcentral gyrus at FU1 (+3weeks) and correlations with 
change in global cognition at the same timepoint (+3weeks) and at a delayed timepoint 
(+3months).  
 
Figure 4.6: Changes in the Fusiform gyrus (VBM) 
(Note: no correlations between VBM changes in the fusiform gyrus and GC changes were found).  
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Vertex-based analysis. Whole-brain correction did not yield any suprathreshold 
results, but two regions were identified for further exploration using small volume 
correction. After small volume correction, there was a significant between-group 
difference in rate of thickness change between baseline and FU2 in the left fusiform 
gyrus (voxel/vertex-wise threshold [vwth] = 3.39, p < 0.001, see Figure 4.7), as well 
as a large cluster in the right parietal lobe covering the supramarginal and postcentral 
gyri (vwth = 2.24, p = 0.006, see Figure 4.8). For both figures below, average 
thickness changes was calculated after exclusion of the single outlier subject in the 
CCT group, as his rate of change was more than 2.5 SDs outside the group average. 
Note that this subject was not excluded in the above Freesurfer vertex analysis.  
Figure 4.7: Vertex-based analysis of the left inferior temporal gyrus.  
 
 
Figure 4.8: Vertex-based analysis of the right supramarginal and postcental gyri. 
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Resting-state fMRI. Compared to baseline, FC between the posterior cingulate and 
the superior frontal gyrus decreased in the CCT group and increased in the AC group 
at FU1 (group x time p<0.01). A statistically significant inverse correlation was found 
between the FC at FU1 and change in GC at FU2 (r=-.602, p=0.038), but only a trend 
towards significance was noted between the two deltas at FU1 (r= -.530, p=0.076, see 
Figure 4.9. No group differences were noted for FC change between the two regions 
at FU2.   
Conversely, FC between the right hippocampus and the superior temporal gyrus 
increased in the CCT group and decreased in the AC group at FU1 (group x time 
p<0.01). A statistically significant correlation was found between FC and GC changes 
at FU1 (r=.603, p=0.038), and a trend towards significance was noted between FC 
change at FU1 and GC change at FU2 (r= .533, p=0.074, see Figure 4.10). No group 
differences were noted for FC between the two regions at FU2. 
  
Figure 4.9: FC changes between the posterior cingulate and superior frontal gyrus at FU1 
(+3weeks) and correlations with GC change at the same timepoint (+3 weeks) and at a delayed 
timepoint (+3months).  
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Figure 4.10: FC changes between the right hippocampus and superior temporal gyrus and 
correlations with GC change at FU1 and 2  
 
 
No significant group x time interactions were found for any of the MRS data (see 
Table 4.1) or DTI analyses (data not shown). 
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Posterior Cingulate 
  
Hippocampus 
 
  
CCT AC p-value 
 
CCT AC p-value 
  
Mean SD Mean SD 
  
Mean SD Mean SD 
 N-acetylaspartate/Cr Baseline 2.23 0.16 2.24 0.28 
0.36 
 
1.74 0.06 1.84 0.06 
0.32  
Follow-up 1 2.14 0.07 2.25 0.29 
 
1.74 0.11 1.72 0.05 
 
Follow-up 2 2.30 0.24 2.26 0.28 
 
1.72 0.15 1.74 0.15 
Cholines/Cr Baseline 0.45 0.07 0.44 0.10 
0.45 
 
1.06 0.05 1.12 0.10 
0.49  
Follow-up 1 0.43 0.03 0.46 0.12 
 
1.09 0.05 1.13 0.17 
 
Follow-up 2 0.42 0.03 0.45 0.11 
 
1.07 0.11 1.17 0.11 
 Myo-inositol/Cr Baseline 1.01 0.14 1.11 0.18 
0.10 
 
1.34 0.11 1.42 0.17 
0.42  
Follow-up 1 1.02 0.13 1.07 0.15 
 
1.34 0.08 1.43 0.23 
 
Follow-up 2 0.98 0.11 1.11 0.20 
 
1.33 0.09 1.48 0.20 
Glutamate+Glutamine/Cr Baseline 0.33 0.07 0.21 0.15 
0.82 
 
0.88 0.19 0.87 0.27 
0.20  
Follow-up 1 0.24 0.08 0.16 0.13 
 
0.88 0.11 0.75 0.17 
 
Follow-up 2 0.23 0.07 0.15 0.12 
 
0.89 0.17 0.90 0.18 
Table 4.1: Metabolite values (normalized to Creatine) at the three time points. No significant time x group interactions were found. P-values refer to time x group 
effect.  
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4.4 Discussion  
CCT effects on cortical thickness in the right postcentral gyrus were observed in a 
whole-brain VBM analysis (net effect size [NES]=1.48) and corroborated by the more 
biologically plausible Freesurfer-based cortical thickness analysis (NES=1.18). The 
postcentral gyrus is among the most age-sensitive cortical regions in terms of both 
volume23-25 and function26, and it is therefore possible that CCT attenuated the  high 
rate of volume loss seen in that region in the control group. Moreover, volume change 
extracted from the VBM analysis correlated with positive change in global cognition, 
further suggesting a possible mechanistic explanation for CCT effects.  
By contrast, between-group structural differences were noted over time in clusters 
around the fusiform and inferior temporal gyri, but the two analytical methods 
localised these to opposite hemispheres (NES=1.43). These findings are in line with 
previous studies in healthy older adults reporting structural10 and functional CT-
induced plasticity12 in these specific segments of the ventral visual cortex, whose 
function also tends to change bilaterally with increasing age27. The effect of CCT 
could be therefore bilateral as well, albeit not robust enough to survive correction.  
Training-induced differences on posterior cingulate–superior frontal gyrus functional 
connectivity (FC) and the hippocampus–superior temporal gyrus FC occurred early in 
the course of training (between baseline and FU1), but were not apparent nine weeks 
later. FC changes were therefore both temporally and spatially different from 
structural changes, suggesting that the two types of imaging can quantify distinct 
neuroplastic mechanisms. Importantly, however, both types of FC changes preceded 
subsequent structural change, and predicted subsequent cognitive change, and may so 
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serve not only as a possible mechanismtic explanation for CCT effect, but also as an 
early biomarker for titration of CCT.  Clearly, given the small scale of this pilot study 
these findings will need replication in a larger study before their significance can be 
properly evaluated. 
Lack of any significant time x group interactions on measures of FA and MRS are 
surprising, as CT-induced effects on these measures have been documented 
previously in healthy elderly. It should be noted, however, that the three studies 
reporting effects on FA11,15,28 and the one study reporting effects on brain metabolites8 
had substantially larger sample sizes than here. Moreover, none of these studies 
included an active control group, and only one (non-randomised) study15 used 
multidomain training. Multidomain training is likely to lead to more spatially 
distributed brain changes than repeated practice on essentially identical tasks over an 
long extended period.       
Overall, the effects sizes generated from the imaging outcomes are higher than the 
GC gains in the overall Timecourse Trial (NES=0.49), but importantly, lower than the 
GC effect size in the imaging subsample (NES=2.18). The utility of neuroimaging as 
a CCT endpoint compared to cognitive endpoints is therefore doubtful5. Replication 
of these effect size estimates is critical, especially in a fully randomised design. 
Subjects in the current study were randomised only at the level of the whole trial, 
their entry into the imaging substudy influenced by a number of convenience factors. 
Arguably, the most useful outcome of this CCT imaging pilot study is therefore the 
ability to design future larger scale studies with some confidence.  
Neuroimaging investigations of CCT may be useful for developing mechanistic 
explanations for training-induced cognitive effects, optimising training programs and 
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predicting response. Since functional outcomes were found to be more sensitive to 
short-term change, they may be more useful than sMRI as predictor of cognitive 
benefits.  
This pilot investigation indeed suggests some intriguing insights into training-induced 
structural and functional plasticity that may explain and complement cognitive 
effects. However, this was a capital- and labour-intensive project, whose costs were 
similar to those spent on two-year Timecourse Trial. Hence, the extent to which the 
potential benefits from neuroimaging investigations of CT outweigh their costs 
remains unclear. 
In conclusion, neuroimaging can provide a unique opportunity for understanding the 
neurobiological underpinnings of CCT2, further development of effective 
interventions for specific neural impairments4, and perhaps as a biomarker for clinical 
response. Further research is required to validate and extend upon these interesting 
preliminary findings. 
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Chapter 5: General Discussion    
I would like to see once, only once in my life, a research report that does not end with 
the words ‘further research is urgently needed’  
Dr. Gerhard Kocher (‘Vorsicht, Medizin!’) 
 
Forty years since CT was suggested as a means to address cognitive ageing1, and 
almost 30 years after the first computerised exercises were trialled2, the field has yet 
to develop a coherent rationale that could serve as a basis for further research, 
development and clinical practice. Tackling this problem will require more than 
simply more studies and more data. As argued in this concluding chapter, meaningful 
progress in the field will require better ways to test, communicate and implement 
CCT programs. Based on the findings described in this thesis, this chapter proposes a 
critical analysis of the current state of the field, and sets forth recommendations to 
strengthen CCT research and ensure its applicability.   
5.1 Summary of Findings 
Chapter 2 is to the best of the candidate’s knowledge the most comprehensive 
systematic review of CCT in healthy older adults so far. It employed strict inclusion 
criteria, most notably randomised controlled designs and computerised interventions, 
and synthesised data from 37 eligible RCTs with 4,310 participants. By means of 
comparison, a recent Cochrane review covering the ill-defined area of ‘cognition-
based interventions’ in healthy elderly and MCI3 found a highly mixed set of 36 
RCTs with 2,229 participants. A similar systematic review incorporating randomised 
along with nonrandomised trials of cognitive interventions in healthy elderly and 
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MCI4 found 35 studies with 2,930 participants, and Kueider et al’s5 systematic review 
of CCT reported data from 38 studies with 3,205 participants, once more combining 
data from RCT with nonrandomised trials and including studies of computer-assisted 
cognitive stimulation along with CCT. 
The findings reported in Chapter 2 are therefore highly specific and up-to-date. They 
can be summarised in five key points. First and foremost, CCT produces small but 
statistically significant effect sizes on measures of memory, working memory, 
attention and visuospatial performance in this age group, as well as medium effect 
sizes on processing speed and language. The latter language effects are discounted 
because of a clear moderating effect of poor study quality. Second, no evidence for 
efficacy on any measure of executive functions was observed. Third, heterogeneity 
across studies was substantial, but is more likely to be explained by specific elements 
of intervention design factors than by a lack of active control groups, publication bias 
or study quality (except for language outcomes). Four, training programs that 
incorporate single-domain training, short sessions (<30 min), and more than three 
sessions per week were generally ineffective. Finally, effects on computerised, 
untrained neuropsychological measures was sometimes larger than on paper-based 
tests, and vice versa, depending on the cognitive domain.  
Further support to these meta-analytical findings were provided in the Timecourse 
Trial in Chapter 3. This is the first RCT to show that centre-based multidomain CCT 
is effective on global cognition (GC), arguably the most relevant deficit in ARCD, 
along with efficacy on composite scores of memory and processing speed, measured 
primarily with computerised neuropsychological assessments. Compared to a rigorous 
active control condition, healthy older adults who received the CCT program showed 
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surprisingly rapid improvements in GC and processing speed, whereas memory gains 
followed a rather linear dose-responsive curve. Follow-up assessments three weeks 
post training revealed a rapid decay in GC and memory gains, whereas processing 
speed remained mainly constant. Two additional follow assessments at 3 and 12 
months post-training showed a continuing moderate decay of gains, but residual 
effects were still noted one year after training cessation. A small effect size 
(NES=0.20) was noted on ADL one year post training, but the trial was not 
sufficiently powered to test statistical significance on this outcome.  
Chapter 4 discusses a pilot study in which a subset of participants from the 
Timcourse Trial (seven from the CCT group and five controls) underwent multimodal 
MRI scans at baseline, then after three weeks and three months of training. We aimed 
to examine the potential of neuroimaging to provide mechanistic explanations for 
CCT-induced cognitive gains, as well as to assess the putative role of neuroimaging 
outcomes as endpoints for CCT trials. Rigorous statistical analyses found CCT-
induced volumetric benefits in two regions implicated in age-related atrophy 
(sensorimotor and ventral visual cortices), as well as positive correlations between 
volumetric changes in the postcentral gyrus and gains in global cognition. Further, we 
found a short-term change in functional connectivity between the posterior cingulate 
and the superior frontal gyrus, as well as between the right hippocampus and superior 
temporal gyrus. Both of these changes preceded structural changes and predicted later 
GC gains. On the other hand, as effect sizes were considerably smaller than those 
obtained from cognitive measures in the same sample, the value of imaging may stem 
mainly from revealing mechanistic changes rather than as biomarkers of intervention 
efficacy, at least as suggested by this modest preliminary investigations of 
multidomain CCT.  
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5.2 Limitations  
The overall aim of this thesis was to address current barriers to wide-scale 
implementation of CCT in the healthy elderly, as well as to guide research priorities 
in the field. Consequently, the work had to be limited to a narrow band of questions 
and analyses, and did not carry out a large number of further analyses that could have 
been of theoretical interest as noted below. Similarly, generalisation of the findings to 
other populations and interventions may be limited.  
In order to increase its relevance to the immediate field, the meta-analysis described 
in Chapter 2 was limited to RCTs of strictly-defined CCT in healthy elderly. This 
decision led to the exclusion of a substantial pool of studies, such as otherwise 
methodologically robust non-randomised trials (e.g., the large COGITO trial6), and 
studies in MCI population, despite the difficulty to distinguish between MCI and 
normal ageing (see Chapter 1). Conversely, neuropsychological outcomes were not 
preselected but rather combined based on general cognitive constructs, and it is 
reasonable to assume that this design decision has decreased the precision of the 
estimated effect. 
As discussed above, the Timecourse Trial (Chapter 3) used a cohort to examine two 
theoretically and methodologically distinct issues, namely the overall long- and short-
term effects of CCT on GC on one hand, and the dose-responsiveness of GC and its 
components on the other. In order to achieve the latter aim, participants in the trial 
underwent essentially the same neuropsychological assessment six times over the 
course of 15 months. This method may have exacerbated test-retest effect in the 
sample, which arguably diminishes the probability of observing transfer from training 
into untrained tasks7. Yet, the fact that significant effects have been observed 
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repeatedly in the data strengthens the argument in favour of CCT efficacy rather than 
weakens it. That said, alternative explanations of theoretical importance such as order 
effect in the battery and the possibility that CCT induces resilience to cognitive 
fatigue rather than increases cognitive capacities7, have not been examined in the 
current study and remain an open field for research.  
Finally, the neuroimaging analyses conducted in a subsample of participants from the 
Timecourse Trial were most certainly limited by the small sample size, a 
disproportional number of CCT vs AC subjects, and gender imbalances between the 
two groups, all of which resulted from practical constraints beyond the control of the 
candidate (see Chapter 4). Thus, although andattempt was made to counterbalance 
these limitations with conservative analytical methods, the results of this pilot version 
must be examined with caution and warrant validation in larger samples.         
      
5.3 Toward the Next Wave of CCT Trials  
The studies conducted in this thesis were designed to address ongoing problems in the 
field of CCT in older adults. Chapter 2 was an effort to shift the evidence base from 
a binary efficacy question (‘does it work?’) to a critical evaluation of specific design 
features (‘what works?’). Chapter 3 provides a novel and concrete example of this 
type of trial, simultaneously addressing the effectiveness of CCT on GC 
(generalisation) and also the temporal dynamics of CCT in terms of dose-
responsiveness and durability across domains. Chapter 4 pushes the field even 
further by posing mechanistic questions (‘how does it work?’), albeit in a preliminary 
form8,9.  
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5.3.1 Increasing Outcome Relevance 
Previous and ongoing CCT trials can be divided into two broad categories. Most have 
focused on simple efficacy questions, a considerably smaller proportion have 
considered moderator and mediator effects, and, in rare cases, conducted head-to-head 
comparisons of different CT programs. This effort has resulted in a plethora of data, 
but given the range of approaches, data synthesis has been a challenge and led to 
wildly divergent conclusions from systematic and non-systematic reviews. Chapter 2 
has to an extent helped address this issue by focusing on potential moderators of 
treatment efficacy in a quantitative manner. 
Yet a more ambitious step towards establishing the ecological validity of CCT may 
require a rethinking of our definition of effectiveness. If the ultimate goal of CCT is 
to maintain elders’ everyday function, reliable measures of the latter will need to be 
developed and implemented as primary outcomes10. At the same time, clear clinical 
outcome measures such as incident diagnosis, mobility and functional independence 
are needed to assess the effectiveness of CCT in primary and secondary prevention of 
dementia. Surrogate outcomes, even global cognition indices, may not provide the 
confidence in the intervention sought by clinicians and decision-makers. On the other 
hand, global and domain-specific cognitive outcomes may continue to be useful for 
more specific purposes such as restoration of specific cognitive impairments at the 
individual level and research about how to best maintain training-induced gains.    
CCT trials are resource-intensive and require a considerable deal of effort on behalf of 
both researchers and participants. Such trials may therefore be difficult to fund, 
recruit and conduct, especially in community settings. Yet, large sample sizes will be 
essential to detection of functional efficacy in healthy elderly. For example, the effect 
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size of NES=0.20 on B-ADL will require a total sample size of N=800 to meet the 
α=0.05 with 0.8 power. The field cannot avoid these any more, as it is this kind of 
clinically- and community- relevant outcomes that changes practice (as witnessed in 
the cardiology field11). What is therefore missing is multicentre networks of like-
minded clinical researchers in order to expedite and efficiently carry out large 
multicentre and even multinational trials. The enhanced definition of likely key 
moderators of CCT efficacy identified in Chapter 2 is a positive contribution to the 
future design of such landmark trials. 
5.3.2 Enhancing Cognitive Efficacy  
Clearly, further work is required to develop evidence-based training protocols that are 
capable of producing durable effects on everyday cognitive health. Three major 
challenges arise:  a tendency for gains to be domain-specific; adherence to demanding 
and time-consuming interventions over the long term; and the limited durability of 
training effects. Possible solutions based on the findings of Chapters 2 and 3 will 
now be discussed in turn.  
Training program. A multidomain training program has the greatest likelihood of 
effectiveness. The program should include both visual and auditory modalities and 
balance training schedules to maintain constant challenge in every targeted domain. In 
principle, training programs should adapt content in difficulty to individual 
performance, based on predefined goals. Regardless of content, 2-3 training sessions 
lasting 30-60 minutes is recommended by the current findings.   
Settings. Similarly to physical training, the effect of CCT relies on a combination of 
factors such as choosing the appropriate exercises, adequate performance, feedback, 
reinforcement, perseverance and emotional satisfaction. Software has limited ability 
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to address all these factors, and is unable to deliver nonspecific factors such as 
socialisation, which are likely to further augment training sessions and are an inherent 
part of centre-based training (and controlled for in active control centre-based 
studies). Although the net contribution of these factors to training efficacy is largely 
unknown in healthy older adults, it may be possible to draft supervision guidelines 
based on methods from the cognitive rehabilitation literature. Moreover, researchers 
and clinicians with an interest in CCT should be taught how to build and supervise 
training sessions, moreover, with some form of certification and quality assurance in 
place. In most countries personal fitness instructors need some form of mandatory 
training and qualification (e.g., in Australia it involves a Certificate IV qualification 
with a minimal course duration of 515 hours); why cognitive fitness instructors do not 
require any minimum training can no longer be defended particularly given the level 
of community and commercial interest.  
Booster. Once a target improvement in cognitive performance has been reached (or 
more likely a ceiling level of improvement as seen in Chapter 3), further training will  
be needed in order to maintain the benefits in the long-term. This may be possible, for 
example, by using distant CCT systems that provide patients with training on their 
personal computers, allow trainers to follow-up on their patients’ performance, and 
enable early detection of decay of cognitive gains that may trigger a face-to-face 
setting. Booster sessions have been found to maintain training benefits one year after 
training cessation, but effects depend on the specific training protocol and outcome 
measures used12-14.   
Targeting executive and everyday functions. As discussed in Chapter 2, further work 
is needed in order to address the current inefficacy of CCT on executive function 
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outcomes. In addition, clinical CCT may adopt methods from the cognitive 
rehabilitation field, targeting specific individual deficits in everyday performance by 
providing training on specific everyday tasks. Such training may be based on 
immersive technologies, which are becoming increasingly affordable and expands the 
quality and variety of computerised rehabilitation techniques. For example, Optale et 
al15 reported gains in several cognitive functions, including GC, in a sample of care 
facility residents following a virtual reality program that trained everyday memory 
tasks using a head-mounted display and joystick. Similarly, Grewe et al16 developed 
3600 virtual supermarket environment, which involve touch screens, sound and 
motion, but has yet to be trialled in older adults.  
5.3.3 Combining Cognitive and Imaging Data to Optimise Training  
A synthesis of the dose-response data discussed in Chapter 3 and 4 may suggest a 
new way for framing multidomain CCT based on the common medical ideas of 
‘loading dose’, ‘titration’ and ‘maintenance dose’ (see Figure 5.1). Initially, we 
observed steep therapeutic response curves, characterized by large gains from 
relatively few training sessions, a period conceptualized as loading dose. These were 
complemented by changes in functional connectivity and a moderate structural 
response in the sensorimotor cortex. Thereafter, global gains continue to rise but 
follow a logarithmic function, where individuals will experience diminishing returns 
as they approach peak therapeutic response. Conversely, the rate of structural change 
has increased compared to the 3-week timepoint, suggesting that structural plasticity 
may follow an exponential function, and that cortical volumes could increase further 
if training would have been continued. Thus, peak-response finding procedure may be 
advantageous at this point (titration). Following the offset of training, therapeutic 
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gains decay quickly, but some residual effects on GC can persist for at least 3-months. 
It is during this time that booster training is indicated and forms the third maintenance 
phase. Currently, there is no biological understanding for how CCT cognitive gains 
decay – and this is a fertile area doe future research. Mechanistic and applied research 
in this field may benefit by clearly distinguishing between these three therapeutic 
phases. 
 
 
Figure 5.1: Therapeutic heuristic for multidomain supervised Computerized Cognitive Training 
in older individuals. Sessions refer to number of consecutive CCT sessions implemented three 
times a week, and time to the equivalent period after stopping training. Three main phases are 
distinguished: loading dose, during which rapid therapeutic effects may be seen; titration, during 
which the trainer identifies peak therapeutic response beyond which further training is 
inefficient; and maintenance, during which rapid decay of gains are lost but residual therapeutic 
effects may be conserved especially with use of booster sessions.  
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5.3.4 Improving Ethical and Reporting Standards  
As scientific and commercial interest in CCT is growing, the impact of the current 
lack of standards or regulation is beginning to surface. Although Chapter 2 did not 
find evidence of publication bias, a close examination reveals some potential issues 
that need to be addressed. More generally, some practices in an already polemical 
field are worrying and warrant a debate about establishing clear guidelines for 
research and communication. 
Inconsistent terminology and reporting standards. As discussed in Chapter 1, the 
terms used to describe cognitive interventions vary to nearly the same extent as the 
interventions themselves. Combined with the typically poorly detailed description of 
the interventions, it may be difficult to replicate previous studies and virtually 
impossible to implement them in clinical practice. This is a substantial and 
preventable waste of research efforts17. It is thus imperative to develop a consensus 
taxonomy for the field, encourage authors to follow them and provide full disclosure 
of critical elements in the CCT intervention, including, among others, public access to 
a training manual that details training protocols, supervision methods and software 
version.  
Conflict of interests. Of the 37 studies reviewed in Chapter 2, 24 (65%) used 
commercially available CCT programs or prototypes of commercial products. There 
is no doubt that CCT should be produced and sold in the marketplace like any other 
medical product or service, and that scientific investigation of these products is 
equally desirable (as done in Chapter 3). Yet, more than half of the studies using 
commercial products were co-authored by employees or financial stakeholders of the 
companies whose products were under investigation. Under these circumstances the 
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degree to which possible conflict of interest has affected reporting remains difficult to 
assess. Like in the wider debate about big-pharma sponsored research, full and open 
access to all primary data may be essential to ensuring confidence in commercial-
CCT sponsored research. 
Clear communication of results to the public. Critics of the multi-million ‘brain 
fitness industry’ sometimes argue that commerce is getting ahead of science and that 
companies’ claims of efficacy largely lack empirical evidence18. Chapter 2 clearly 
shows that this argument is not correct for CCT as a whole, but does not neutralise the 
argument. Insofar as academic integrity is concerned, CCT researchers should not 
limit their role to simple academic conduct and reporting, but also to ensuring that 
research findings are not misused and championing higher standards for the field in 
general.  
5.4 Conclusion 
ARCD is a major concern for Australia’s rapidly ageing population and an existential 
threat to the Australian economy. CCT is among the very few interventions that can 
improve cognitive performance in the elderly19, and is therefore a candidate 
intervention for primary and secondary prevention.  
The ‘brain training debate’ is therefore, hopefully, over. At the very least the 
conversation needs to change. This thesis makes a strong case for the efficacy of CCT 
on elders’ cognitive performance. It also reveals a number of crucial design factors 
that underpin effective CCT, showed that these effects are dose-dependent, charted 
their short- and long-term dose response curves, and provided insights for how 
neuroimaging can be used to reveal potential underlying mechanisms. Beyond this, 
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this thesis is the first to show robust and durable CCT-induced gains on global 
cognition, hence taking the field towards its next challenge – establishing 
effectiveness on everyday function and ultimately as a possible means to better 
prevent dementia.  
This thesis must therefore conclude with only a partial fulfilment of Dr Kocher’s 
wish: that not more research is required but different research. The time has come to 
begin to establish consensus guidelines around CCT, impose training standards for the 
field, design large clinical trials that can deliver results of greater relevance, and 
disseminate these results in a useful and unambiguous manner. Novelty in the field 
will not stem from yet another medium-sized trial of a yet another CCT program, but 
rather by examining its clinical and societal relevance.  
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Appendix 1: COGPACK Training Schedule    
Session Exercises used 
Session 1 Reading UFOs Color&Labels New-or-Not Logic Anagrams 
  Session 2 Route Sequences Scales Comparisions Compass Mathematics  
 Session 3 Sequence Eyewitness Archive Ball Search Position 
  Session 4 Reading Sequences New-or-Not Connect Clock Labyrinths 
  Session 5 Memory Sequences Route Reaction Follow-up Color&Labels Anagrams Position 
Session 6 Eyewitness Scales Comparisions Compass Archive Numbers 
  Session 7 Reading Sequences UFOs Logic Guess Words Search Position 
 Session 8 Memory Sequences Connect Clock Route Numbers 
  Session 9 Eyewitness Sequences Color&Labels Guess Words Logic Archive Position 
 Session 10 Sequence New-or-Not Scales Comparisions Compass Mathematics  
 Session 11 Memory Route Reaction Logic Search Guess Words Position 
 Session 12 Eyewitness Sequences Archive Connect Labyrinths Numbers 
  Session 13 Reading Sequences New-or-Not UFOs Color&Labels Guess Words Position 
 Session 14 Route Sequences Scales Comparisions Compass Mathematics  
 Session 15 Eyewitness Sequences Archive Ball Logic Search Position 
 Session 16 Reading Sequences New-or-Not Connect Mathematics Clock Labirynths 
 Session 17 Memory Sequences Route Reaction Logic Guess Words Position 
 Session 18 Eyewitness Sequences Archive Comparisions Compass Mathematics  
 Session 19 Reading UFOs New-or-Not Logic Sequences Search Guess Words Position 
Session 20 Memory Sequences Connect Clock Labyrinths Numbers 
  Session 21 Sequence Ball Follow-up Color&Labels Archive Concepts Position 
 Session 22 Piece-work Wisdom New-or-Not Scales Comparisions Mathematics  
 Session 23 Memory Route Sequence Who-or-What Clock Position 
  Session 24 Labyrinths Eyewitness Archive Sequence Numbers Clock Reaction 
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Session 25 Wisdom New-or-Not Sequence Logic Color&Labels Who-or-What Position 
 Session 26 Memory Route Scales Comparisons Compass 
   Session 27 Eyewitness Ball Logic Search Sequences Concepts Archive Position 
Session 28 New-or-Not Connect Labyrinths Numbers Sequences Logic 
  Session 29 Wisdom Archive Sequence UFOs Search Position 
  Session 30 Eyewitness Route Sequence Scales Color&Labels Compass 
  Session 31 Memory Sequences Follow-up Clock Guess Words Numbers Position 
 Session 32 Reading New-or-Not Sequence Ball Color&Labels Labyrinths 
  Session 33 Memory Route Sequence Logic Connect Mathematics  
 Session 34 Sequence Who-or-What Comparisions Reaction Archive Search 
  Session 35 Wisdom New-or-Not Compass Scales Mathematics Logic Position 
 Session 36 Sequence Reaction Clock Color&Labels Concepts Route 
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Appendix 2: COGPACK Exercise Descriptions  
Note: The descriptions below are based on exercise descriptions provided in 
COGPACK version8 help files. COGPACK is copyrighted by Marker Sofware, 
Landenburg, Germany.     
Anagrams: A meaningful word must be made out of the letters provided. This 
exercise trains the use of meaningful linguistic material at word-level.  
Archive: The$trainee$is$given$titles$to$pictures,$and$must$then$remember$them$either$actively$or$passively.$$
Ball: The trainee must keep a ball bouncing using a horizontally movable paddle. 
This exercise trains visuomotor skills.  
Clock: Set and read an analogue clock. 
Color & Labels: Task 1 - Colour labels are written in the colour they mean (e.g. 
word blue is written in blue), with one exception (e.g. word green is written in red). 
The wrong colour label must be clicked on. Task 2 - A block of colours or patterns 
displays all but one of the selections shown in a multiple choice list. The missing one 
has to be found. Task 3 - Short-term memory tasks with colours and labels. 
Comparisons: Compare two simultaneously appearing character strings. 
Compass: Recognize and enter compass points using on-screen compass 
Concepts: Work out the concept/rule linking various terms. This exercise trains 
meaningful linguistic material at concept level. 
Connect: Using mouse clicks, join up points according to given rules 
Eyewitness: Trainees must recall short street scenes with random combinations of 
image, text, sound and movement elements. This exercise trains quick perception and 
passive reproduction of several simultaneous stimuli. 
Follow-up: Continue a series of characters according to deducible rules. 
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Guess Words: Based on word length and definition, trainees must guess a word using 
the fewest number of letter clues. This exercise trains meaningful linguistic material 
at a relatively simple word-level. 
Labyrinths: Using the mouse or cursor keys, trainees must sscape from randomly 
generated labyrinths which only have one solution and one exit.  
Logic: Task 1 –Formal comparison of abstract quantities. This exercise trains 
deductive thinking. Task 2 – Complete a block of regularly ordered characters. Rule 
recognition. Like many intelligence tests. Task 3 –  Logical “AND and OR” 
exercises. LOGIC “And and Or” is designed for learning some basic rules of logical 
combination.  
Mathematics: Trainees must solve arithmetic problems, complex puzzles and 
problems using basic algebra and tasks which use everyday problems (percentages, 
sales tax). 
Memory: Trainees are required to solve memory tasks using selectable material (e.g. 
text, graphics) and selectable recall options (e.g. immediate or delayed).  
New-or-Not: Numerous items will be presented on the screen, and trainees must 
indicate if they have seen the item previously.  
Numbers: Numerals expressed in roman, binary, hexadecimal form or in words from 
various languages must be entered in arabic-decimal numbers or vice versa 
Piece-work: This is a simulation of an assembly line. Trainees must remove defective 
pieces. 
Position: The position of 3-D bodies in space must be remembered or reproduced 
Reaction: This exercise trains reaction rime, and requires trainees to respond to 
certain stimulus as quickly as possible according to given instructions 
Reading: Trainees must memorize presented texts and then answer questions on it.   
Route: Trainees must follow must note the route indicated on a map and then must 
reproduce this.   
Scales: Scales must be brought into balance using as few as possible of the weights 
available. 
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Search: Trainees must search for a particular item hidden in a distracting background.   
Sequence: A set of continuous performance tasks. Trainees must rapidly click on 
items based on their relationship to previous items according to a given rule.   
UFOs: Use the mouse to catch UFOs flying in from random directions. This exercise 
trains hand-eye coordination.  
Who-or-What: Task 1 - The description of a person or a concept is given either letter 
by letter or as running letters. As soon as the item has been guessed, the stop button 
must be pressed and the answer entered. Task 2 - Trainees must match labels to 
pictures. 
Wisdom: Trainees must memorize quotes and the individuals who said them. 
 
 
